TY - JOUR
AU - HARRIS, JOHN E.
AB - References 1. Marshall, E. K.: The Dosage Schedule of Chemotherapeutic Agents , Pharmacol. Rev. 4:85-105, 1952 2. Birnbaum, D., and Hollander, F.: Inhibition of Pancreatic Secretion by the Carbonic Anhydrase Inhibitor, 2-Acetylamino-1,3,4-Thiadiazole-5-Sulfonamide (Compound #6063) , Proc. Soc. Exper. Biol. & Med. 81:23, 1952. 3. Janowitz, H. D.; Colcher, H., and Hollander, F.: Carbonic Anhydrase Inhibition and Gastric Secretion , Tr. New York Acad. Sc. 15:54, 1952. 4. Maren, T. H.: Pharmacological and Renal Effects of Diamox (6063) a New Carbonic Anhydrase Inhibitor , Tr. New York Acad. Sc. 15:53, 1952. 5. McGowan, J. A.; Stanley, M. M., and Powell, J. J.: Effect of 2-Acetylamino-1,3,4-Thiadiazole-5-Sulfonamide (6063: Diamox) on the Secretion of Gastric Hydrochloric Acid in Man , Bull. New England M. Center 14:117-121, 1952. 6. Wyss, O.; Smith, G. N.; Hobby, G. L.; Oginsky, E. L., and Pratt, R.: Symposium on the Mode of Action of Antibiotics , Bact. Rev. 17:17-49, 1953. 7. Sacks, L. E.: Subtilin Considered as a Germicidal Surface-Active Agent , Antibiotics & Chemother. 2:79-85, 1952. 8. Tolstoouhov, A. V.: Physical-Chemical Approach to the Problems of Chemotherapy , Tr. New York Acad. Sc. 14:260, 1952. 9. Bergmann, E. D., and Sicher, S.: Mode of Action of Chloramphenicol , Nature, London 170:931-932, 1952. 10. Bernheim, F., and De Turk, W. E.: Effect of Chloramphenicol and Certain Other Drugs on the Oxidation of Aromatic Amino Acids by a Strain of Pseudomonas Aeruginosa , J. Pharmacol. & Exper. Therap. 105:246, 1952. 11. Long, P. H.: Mode of Action of Antibiotics , New York J. Med. 52:1637-1639, 1952. 12. Miura, Y.; Nakamura, Y.; Matsudaira, H., and Komeiji, T.: Mode of Action of Terramycin , Antibiotics & Chemother. 2:152-158, 1952. 13. Umbreit, W. W., and Oginsky, E. L.: Mode of Action of Antibiotics: Penicillin and Streptomycin , J. Mt. Sinai Hosp. 19:175, 1952. 14. Van Meter, J. C.; Spector, A.; Oleson, J. J., and Williams, J. H.: In Vitro Action of Aureomycin on Oxidative Phosphorylation in Animal Tissues , Proc. Soc. Exper. Biol. & Med. 81:215, 1952. 15. Eagle, H.; Levy, M., and Fleishman, R.: Effect of the pH of the Medium on the Antibacterial Action of Penicillin, Streptomycin, Chloramphenicol, Terramycin, and Bacitracin , Antibiotics & Chemother. 2:563-575, 1952. 16. Weinberg, E. D.: Influence of Various Sources of Nitrogen on the Activity of Antibiotics , Antibiotics & Chemother. 2:130-134, 1952. 17. Levaditi, C.: Pour quelles raisons les antibiotiques n'agissent-ils pas sur les ultravirus? Presse méd. 60:133-134, 1952. 18. Haight, T. H., and Finland, M.: Observations on Mode of Action of Erythromycin , Proc. Soc. Exper. Biol. & Med. 81:188, 1952. 19. Eagle, H.: Experimental Approach to the Problem of Treatment Failure with Penicillin: I. Group A Streptococcal Infection in Mice , Am. J. Med. 13:389-399, 1952. 20. Schoenhard, D. E., and Stafseth, H. J.: Some Observations on the in Vitro Action of Neomycin , Antibiotics & Chemother. 2:41-50, 1953. 21. Brownlee, G.; Bushby, S. R. M., and Short, E. I.: Chemotherapy and Pharmacology of the Polymyxins , Brit. J. Pharmacol. 7:170-188, 1952. 22. Dunitz, J. D., and Robertson, J. H.: Relationship Between Aureomycin and Terramycin , J. Am. Chem. Soc. 74:1108, 1952.Crossref 23. Pepinsky, R., and Watanabe, T.: Isomorphism of Terramycin and Aureomycin Hydrochlorides , Science 115:541-543, 1952.Crossref 24. Regna, P. P.: Chemical Structure of Terramycin in Relation to Mode of Action , Tr. New York Acad. Sc. 15:12, 1952.Crossref 25. Collins, R. J.; Ellis, B.; Hansen, S. B.; Mackenzie, H. S.; Moualim, R. J.; Petrow, V.; Stephenson, O., and Sturgeon, B.: Some Observations on the Structural Requirements for Antibiotic Activity in the Chloramphenicol Series: II. J. Pharm. & Pharmacol. 4:693-710, 1952. 26. Umbreit, W. W.: Symposium on Chemical Structure of Antibiotics in Relation to Mode of Action: Streptomycin , Tr. New York Acad. Sc. 15:8-12, 1952. 27. Arnrich, L.; Lewis, E. M., and Morgan, A. F.: Growth of Dogs on Purified Diet Plus Aureomycin and/or Vitamin B12. Proc. Soc. Exper. Biol. & Med. 80:401-404, 1952. 28. Brown, P. B.; Becker, D. E.; Terrill, S. W., and Card, L. E.: Effect of Aureomycin on the Growth and Metabolism of the Pig , Arch. Biochem. 41:378-382, 1952. 29. Cuthbertson, W. F. J.: Nutritional Significance of the Animal Protein Factor and Antibiotics , Brit. J. Nutrition 6:330-335, 1952. 30. Lawrence, J. M., and McGinnis, J.: Effect of Terramycin on the Growth of Rabbits , Arch. Biochem. 37:164-166, 1952. 31. Weber, E. M.; Luther, H. G., and Reynolds, W. M.: Antibiotics as Animal-Growth Stimulants , Bull. World Health Organ. 6:149-161, 1952. 32. Meites, J.: Beneficial Effects of Vitamin B12 and Aureomycin in Rats Given Large Doses of Cortisone , Proc. Soc. Exper. Biol. & Med. 81:307, 1952. 33. Nickell, L. G.: Stimulation of Plant Growth by Antibiotics , Proc. Soc. Exper. Biol. & Med. 80:615-617, 1952. 34. Furth, F. W.: Coulter, M. P., and Howland, J. W.: Effect of Aureomycin on the Radiation Syndrome in Dogs , Am. J. Path. 28:25-36, 1952 35. Effect of Aureomycin and Terramycin on the X-Radiated Rat , Furth Am. J. Path. 28:185-191, 1952. 36. Kaplan, H. S.; Speck, R. S., and Jawetz, E.: Impairment of Antimicrobial Defenses Following Total Body Irradiation of Mice , J. Lab. & Clin. Med. 40:682, 1952. 37. Birnstingl, M. A.; Shooter, R. A., and Hunt, M. G.: Sensitivity to 5 Antibiotics of Strains of Staph. Pyogenes Isolated from Out-Patients , Brit. M. J. 1:253-254, 1952. 38. Koch, M. L., and Bourgeois, R. W.: Report on a Further Increase in the Incidence of Drug-Resistant Pathogenic Staphylococci Encountered in the Hospital Laboratory , Antibiotics & Chemother. 2:229-233, 1952. 39. Lund, E.: Determination of the Sensitivity of Bacteria to Aureomycin, Chloromycetin, and Terramycin , Acta path. et microbiol. scandinav. 31:281-288, 1952. 40. Wilson, R., and Cockcroft, W. H.: Penicillin Resistant Staphylococcal Infection , Canad. M. A. J. 66:548-551, 1952. 41. Cavalli, L. L.: Genetic Analysis of Drug-Resistance , Bull. World Health Organ. 6:185-206, 1952. 42. Sevag, M. G., and Rosanoff, E. I.: Mechanism of the Development of Resistance to Streptomycin: I. Origin of Resistant Strains , J. Bact. 63:243-251, 1952. 43. Welsch, M.: Some Aspects of Microbial Resistance to Streptomycin , Bull. World Health Organ. 6:173-183, 1952. 44. Fusillo, M. H.; Romansky, M. J., and Kuhns, D. M.: Further Investigations on Cross Resistance as Well as Studies on Induced Sensitivity to the Antibiotics , Antibiotics & Chemother. 3:35-41, 1953. 45. Woodard, W. A.: Recent Developments in the Pharmacy of Antibiotics , J. Pharm. & Pharmacol. 4:1009, 1952. 46. Fisher, A. M.: A Trial of Oral Penicillin , New Zealand M. J. 51:418-419, 1952. 47. Lepper, M. H.; Rodriguez, J.; Blatt, N., and Spies, H. W.: Use of Dibenzylethylenediamine Penicillin Administered Orally in Bacterial Infections , Antibiotics & Chemother. 2:175-178, 1952. 48. Boger, W. P.; Crosley, A. P., Jr.; Carfagno, S., and Bayne, G. M.: Oral Penicillin and "Benemid" Compared with Intramuscular Repository Procaine Penicillin , Antibiotics & Chemother. 2:555-563, 1952. 49. Frisk, A. R.; Diding, N., and Wallmark, G.: Influence of Probenecid on Serum Penicillin Concentration After Oral Administration of Penicillin , Scandinav. J. Clin. & Lab. Invest. 4:83-89, 1952. 50. Verwey, W. F.; Miller, A. K., and Schlottman, D. W.: Effect of "Benemid" and Carinamide on Penicillin Therapy of Experimental Pneumococcic Infections in Mice , Proc. Soc. Exper. Biol. & Med. 79:500-503, 1952. 51. Glazko, A. J.; Edgerton, W. H.; Dill, W. A., and Lenz, W. R.: Chloromycetin Palmitate—A Synthetic Ester of Chloromycetin , Antibiotics & Chemother. 2:234-242, 1952. 52. Ross, S.; Burke, F. G., and Rice, C. E.: Use of Chloromycetin Palmitate in Infants and Children: A Preliminary Report , Antibiotics & Chemother. 2:199-207, 1952. 53. Finn, J. J., and Kane, L. W.: Magnamycin, a New Antibiotic , Bull. New England M. Center 14:113, 1952. 54. Josselyn, L. E., and Sylvester, J. C.: Absorption of Erythromycin , Antibiotics & Chemother. 3:63-67, 1953. 55. Hunt, A. D., Jr.; Kelley, R. S.; Coriell, L. L.; Murphy, M. L.; Tashman, S. G., and Stevens, C.: Absorption and Distribution of Terramycin in Children , Pediatrics 9:607-616, 1952. 56. Siegel, A. C.; Nickerson, G. H., and Cook, C. D.: Rectal Administration of Aureomycin in Children , New England J. Med. 246:447-449, 1952. 57. Heilman, F. R.; Herrell, W. E.; Wellman, W. E., and Geraci, J. E.: Some Laboratory and Clinical Observations on a New Antibiotic, Erythromycin (Ilotycin) , Proc. Staff Meet., Mayo Clinic 27:285-304, 1952. 58. Flippin, H. F.; Matteucci, W. V.; Schimmel, N. H.; Bartholomew, L. E., and Boger, W. P.: The Hydriodide of Diethylaminoethyl Ester of Penicillin G, Neo-Penil , Antibiotics & Chemother. 2:208-214, 1952. 59. Flippin, H. F.; Unangst, W. W.; Schimmel, N. H.; Bartholomew, L. E., and Matteucci, W. V.: The Hydriodide of Diethylaminoethyl Ester of Penicillin G, Neo-Penil: II. J. Philadelphia Gen. Hosp. 3:57-60, 1952. 60. Grigsby, M. E.; Haight, T. H., and Finland, M.: Some Clinical and Laboratory Observations on the Hydriodide of Diethylaminoethyl Ester of Penicillin G (Neo-Penil) , New England J. Med. 247:807-811, 1952. 61. McDonald, G. L., and Thomson, E. F.: Penicillin Levels in the Sputum Following Intramuscular Injections of "Estopen," M. J. Australia 2:407-408, 1952. 62. Nielson, A. T., and Roholt, K.: A Note on Benzylpenicillin Diethylaminoethyl Ester , J. Pharm. & Pharmacol. 4:266-267, 1952. 63. Rhodes, R. E.; Parmelee, E. T., and Ferlauto, R. J.: β-Diethylaminoethyl Ester of Benzyl Penicillin: I. A Preliminary Report on Tissue Compounds , Antibiotics & Chemother. 2:389-393, 1952. 64. Schimmel, N. H.; Wilson, W. W.; Matteucci, W. V., and Flippin, H. F.: The Hydriodide of Diethylaminoethylester Penicillin-G, Neo-Penil: III. Unusually High Penicillin Concentrations in Cerebrospinal Fluid Following Intramuscular Administration , Am. J. M. Sc. 224:247-251, 1952. 65. Hallas-Moller, K.; Juncher, H. O.; Moller, C., and Wille, B.: Chemical and Biological Investigations of an Organ-Specific Derivative of Penicillin: The Hydriodide of the Benzyl Penicillin—Diethyl—Aminothanol Ester , Antibiotics & Chemother. 2:334-343, 1952. 66. (a) Cannon, E. J.; Nichols, A. C., and Leopold, I. H.: Studies on the Intraocular Penetration and Toxicity of Terramycin , A. M. A. Arch. Ophth. 47:344-349, 1952. 67. (b) Ainslie, D., and Smith, C.: Polymyxin E Penetration into the Eye and Therapeutic Value of Experimental Infection Due to Ps. Pyocyanea , Brit. J. Ophth. 36:352-361, 1952. 68. (c) Sorsby, A.; Ungar, J., and Bailey, N. L.: Streptomycin in Ophthalmology , Brit. M. J. 1:119-123, 1952. 69. Finland, M. F., and Weinstein, L.: Complications Induced by Antimicrobial Agents , New England J. Med. 248:220-226, 1953. 70. McCurdy, R. S., and Neter, E.: Effects of Penicillin and Broad-Spectrum Antibiotics on Emergence of a Gram-Negative Bacillary Flora in the Upper Respiratory Tract of Infants , Pediatrics 9:572-576, 1952. 71. McGovern, J. J.; Parrot, R. H.; Emmons, C. W.; Ross, S.; Burke, F. G., and Rice, E. C.: Effect of Aureomycin and Chloramphenicol on the Fungal and Bacterial Flora of Children , New England J. Med. 248:397-403, 1953. 72. Yow, E. M.: Development of Proteus and Pseudomonas Infections During Antibiotic Therapy , J. A. M. A. 149:1184-1187, 1952. 73. Seligmann, E.: Virulence-Enhancing Activities of Aureomycin on Candida Albicans , Proc. Soc. Exper. Biol. & Med. 79:481-484, 1952. 74. Reyer, W. A.: A Study in the Pathogenesis and Classification of Dermatologic Penicillin Reactions , Ann. Allergy 10:270-277, 1952. 75. Evans, F., and Gould, J.: Relation Between Sensitivity to Thiopentone, Sulphonamides, and Sulphathiazole , Brit. M. J. 1:417-419, 1952. 76. Ghosh, M. N.: Fixed Eruption Due to Sulphonamide Hypersensitivity , Brit. M. J. 2:26, 1952. 77. Jeffrey, B.; Borrie, P., and MacDonald, N.: Acquired Hypersensitivity to Sodium PAS, Streptomycin, and Penicillin , Brit. M. J. 2:647-649, 1952. 78. Kooij, R., and van Vloten, T. J.: Epidermal Sensitization Due to Sulphonamide Drugs: Groups- and Cross-Sensitivity; Photosensitivity; Passive Transfer of Antibodies; Leftwich Reaction , Dermatologica 104:151-167, 1952. 79. Seeberg, G.: Demonstration of Antibodies in Streptomycin Eczema by the Collodion Agglutination Test , Acta dermat.-venereol. 32:355-363, 1952. 80. Theodore, F. H.: Drug Sensitivities and Irritations of the Conjunctiva , J. A. M. A. 151:25-30, 1953. 81. Riley, K. A.: Serum Sickness from Penicillin: A Report of 22 Cases , A. M. A. Arch. Dermat. & Syph. 65:727, 1952. 82. Christenson, W. N.; Hedrick, G. W., and Schugmann, R. F.: Fatal Anaphylactic Reaction Following Penicillin Injection , U. S. Armed Forces M. J. 4:249-252, 1953. 83. Higgins, G. A., and Rothchild, T. P. E.: Fatal Anaphylactic Shock from Procaine Penicillin , New England J. Med. 247:644-646, 1952. 84. Mayer, P. S.; Mosko, M. M.; Schutz, P. J.; Osterman, F. A.; Steen, L. H., and Baker, L. A.: Penicillin Anaphylaxis , J. A. M. A. 151:351-353, 1953. 85. Siegal, S.; Steinhardt, R. W., and Gerber, R.: Fatal and Near-Fatal Penicillin Anaphylaxis , J. Allergy 24:1, 1953. 86. Thomson, W. O.: Sudden Death Following an Injection of Penicillin , Brit. M. J. 2:70-72, 1952. 87. Farber, J. E., and Ross, J.: Antibiotic Anaphylaxis , M. Times 80:28-30, 1952. 88. Maslansky, L., and Sanger, M. D.: A Method of Decreasing Penicillin Sensitivity , Antibiotics & Themother. 2:385-388, 1952. 89. MacKay, C. R.: Failure of Antihistamine Therapy in Severe Sulfadiazine Hypersensitivity , Rocky Mountain M. J. 49:441-442, 1952. 90. Presnell, C. A.: Use of Staphylococcus Toxoid in the Treatment of Allergic Penicillin Reactions , Tr. Am. Acad. Ophth. 56:276-279, 1952. 91. Claudon, D. B., and Holbrook, A. A.: Fatal Aplastic Anemia Associated with Chloramphenicol (Chloromycetin) Therapy , J. A. M. A. 149:912-913, 1952. 92. Cone, T. E.: Aplastic Anemia Following Two Days of Chloramphenicol Therapy , J. Pediat. 41:340, 1952. 93. Freedman, M. H.: Aplastic Anemia Following the Administration of Chloramphenicol (Chloromycetin) , J. M. A. Georgia 41:456, 1952. 94. Hargraves, M. M.; Mills, S. D., and Heck, F. J.: Aplastic Anemia Associated with Administration of Chloramphenicol , J. A. M. A. 149:1293-1300, 1952. 95. Hawkins, L. A., and Lederer, H.: Fatal Aplastic Anemia After Chloramphenicol Treatment , Brit. M. J. 2:423-426, 1952. 96. Loyd, E. L.: Aplastic Anemia Due to Chloramphenicol , Antibiotics & Chemother. 2:1-4, 1952. 97. Rheingold, J. J., and Spurling, C. L.: Chloramphenicol and Aplastic Anemia , J. A. M. A. 149:1301-1303, 1952. 98. Robinson, H. M.; Zeligman, I.; Shapiro, A., and Cohen, M. M.: Leukopenia, a Complication of Chloromycetin Therapy of Chronic Discoid Lupus Erythematosus , J. Invest. Dermat. 19:199-204, 1952. 99. Smiley, R. K.; Cartwright, G. E., and Wintrobe, M. M.: Fatal Aplastic Anemia Following Chloramphenicol (Chloromycetin) Administration , J. A. M. A. 149:914-917, 1952. 100. Sturgeon, P.: Fatal Aplastic Anemia in Children Following Chloramphenicol (Chloromycetin) Therapy , J. A. M. A. 149:918-921, 1952. 101. Wilson, L. E.: Harris, M. S.; Henstell, H. H.; Witherbee, O. O., and Kahn, J.: Aplastic Anemia Following Prolonged Use of Chloramphenicol , J. A. M. A. 149:231-234, 1952.Crossref 102. Wolman, B.: Fatal Aplastic Anaemia After Chloramphenicol , Brit. M. J. 2:426-427, 1952.Crossref 103. Hargraves, M. M.; Mills, S. D., and Heck, F. J.: Aplastic Anemia Associated with the Administration of Chloramphenicol , Proc. Staff Meet., Mayo Clinic 27:280-281, 1952. 104. Geiger, J.: Thrombocytopenic Purpura Induced by Sulfisoxazole (Gantrisin®) Therapy , J. A. M. A. 149:1219-1220, 1952.Crossref 105. Gilbert, F. I., Jr., and Arnold, H. J., Jr.: Failure of Corticotropin to Prevent Acute Hemolytic Anemia Due to Sulfapyridine , J. A. M. A. 150:95-96, 1952.Crossref 106. Ingram, G. I. C., and Armitage, P.: Effect of Penicillin and of Streptomycin on Blood Coagulation in Normal Subjects , J. Pharm. & Pharmacol. 4:1047-1062, 1952. 107. Parker, J. W., Jr., and Wright, L. T.: Effect of Terramycin and Aureomycin on Blood Coagulation , Science 116:282-284, 1952. 108. Brown, R. L.: The Gastrointestinal Tract and Stool Following Aureomycin Therapy , Antibiotics & Chemother. 2:5-11, 1952. 109. Reiner, L.; Schlesinger, M. J., and Miller, G. M.: Pseudomembranous Colitis Following Aureomycin and Chloramphenicol , A. M. A. Arch. Path. 54:39-68, 1952. 110. Catanzaro, F. J.; Ostfeld, A. M., and Bergner, G. E.: Low Salt Syndrome During Treatment with Chloramphenicol , J. A. M. A. 149:571-572, 1952. 111. Sarett, H. P.: Effect of Oral Administration of Streptomycin on Urinary Excretion of B Vitamins in Man , J. Nutrition 47:275-287, 1952. 112. Bateman, J. C.; Barberio, J. R.; Cromer, J. K., and Klobb, C. T.: Investigation of Mechanism and Type of Jaundice Produced by Large Doses of Parenterally Administered Aureomycin , Antibiotics & Chemother. 3:1-16, 1953. 113. Cutting, W. C.: Liver Changes Produced by Aureomycin and Terramycin , Stanford M. Bull. 10:18, 1952. 114. Rutenburg, A. M., and Pinkes, S.: Hepatotoxicity of Intravenous Aureomycin , New England J. Med. 247:797-800, 1952. 115. Short, E. I.: Mechanism of Methionine Protection Against the Nephrotoxicity of Polymyxin A , Brit. J. Pharmacol. 7:248-254, 1952. 116. Light, A. E.; Tornaben, J. A., and DeBeer, E. J.: Comparison of the Renal Effects of Polymyxin A, Aerosporin and a Mercurial Diuretic , Antibiotics & Chemother. 2:63-71, 1952. 117. Don, C., and Gregory, J.: Toxicity of Dihydrostreptomycin Sulphate for the Auditory Nerve , Lancet 1:72-75, 1952. 118. Naismith, J. T.: Deafness with Use of Dihydrostreptomycin in Tuberculous Meningitis , Brit. M. J. 1:796-798, 1952. 119. Wallenstein, L., and Snyder, J.: Neurotoxic Reaction to Chloromycetin , Ann. Int. Med. 36:1526-1527, 1952. 120. Mattsson, R.: Transient Myopia Following the Use of Sulphonamides , Acta ophth. 30: 385-398, 1952. 121. Gardocki, J. F., and others: Magnamycin: Toxicity in Experimental Animals , Antibiotics & Chemother. 3:55-63, 1953. 122. Brown, R. K.: Influence of Modern Antibiotics on Abdominal Surgery , New York J. Med. 53:171-175, 1953. 123. Lawrence, F. S.: Present Role of the Sulphonamides , Practitioner 168: 180-190, 1952. 124. Macdonald, J. B.: Principles of Antibiotic Therapy , J. Canad. Dent. A. 18:458-463, 1952. 125. Patterson, R. H., and Bromberg, B.: Influence of Antibiotics in the Surgical Treatment of Injuries and Infections of the Extremities , New York J. Med. 53:176-181, 1953. 126. Shea, J. J., and Shea, J. J., Jr.: Use and Abuse of the Antibiotics in Otolaryngology , Eye, Ear, Nose & Throat Month. 31:647-651, 1952. 127. Waisbren, B. A.: A Point of View in Regard to the Use of Antibiotics , Marquette M. Rev. 17:51-57, 1952. 128. Forbes, M. A., Jr.: A Clinical Evaluation of Neomycin in Different Bases , South. M. J. 45:235-239, 1952. 129. Kile, R. L.; Rockwell, E. M., and Schwarz, J.: Use of Neomycin in Dermatology , J. A. M. A. 148:339-343, 1952. 130. Livingood, C. S.; Nilasena, S.; King, W. C.; Stevenson, R. A., and Mullins, J. F.: Pyogenic Infections Treated with Neomycin , J. A. M. A. 148:334-339, 1952. 131. Ravina, A.: Une nouvelle indication, peut-être primordiale, de la néomycine: Le traitment des infections cutanées , Presse, méd. 60:1237-1238, 1952. 132. Rattner, H., and Rodin, H. H.: Treatment of Pyodermas with Penicillin 92: Comparison with Neomycin and Bacitracin , A. M. A. Arch. Dermat. & Syph. 65:656, 1952. 133. Leopold, I. H.: Surgery of Ocular Trauma , A. M. A. Arch. Ophth. 48:738-746, 1952. 134. Kiser, J. S.; de Mello, G. C.; Reichard, D. H., and Williams, J. H.: Chemotherapy of Experimental Clostridial Infections , J. Infect. Dis. 90:76-80, 1952. 135. Sandusky, W. R.; Keeble, C. F.; Wharton, W. P., and Taylor, R. N.: Prophylactic Use of Terramycin in Experimental Clostridium Welchii Infection in Guinea Pigs , Surgery 31:365-366, 1952. 136. Taylor, W. I., and Novak, W.: Antibiotic Prophylaxis of Experimental Clostridial Infections: I. Antibiotic Prophylaxis of Tetanus , Antibiotics & Chemother. 2:517-520, 1952 137. II. Penicillin Prophylaxis of Clostridium Perfringens and Clostridium Septicum Infections , Taylor Antibiotics & Chemother. 2:576-580, 1952. 138. Callahan, A.: Effects of Sulfonamides and Antibiotics on Panophthalmitis Complicating Cataract Extraction , A. M. A. Arch. Ophth. 49:212-219, 1953. 139. Lehr, D.: Comparative Merits of 3,4-Dimethyl-5-Sulfanilamide-Isoxazole (Gantrisin) and a Sulfapyrimidine Triple Mixture , Antibiotics & Chemother. 3:71-94, 1953. 140. Warren, C. M., Jr.: Local Treatment of Eye Infections with Gantrisin , South. M. J. 45:1183-1185, 1952. 141. English, A. R.; Mullady, H. E., and Fitts, R. A.: Magnamycin: II. In Vivo Studies , Antibiotics & Chemother. 3:94-98, 1953. 142. Haight, T. H., and Finland, M.: Laboratory and Clinical Studies on Erythromycin , New England J. Med. 247:227-232, 1952 143. Resistance of Bacteria to Erythromycin , Proc. Soc. Exper. Biol & Med. 81:183-188, 1952. 144. Tanner, F. W., Jr.; English, A. R.; Lees, T. M., and Routien, J. B.: Some Properties of Magnamycin, A New Antibiotic , Antibiotics & Chemother. 2:441-443, 1952. 145. Trafton, H. M.; Lind, H. E., and Correia-Branco, M.: Treatment of Urinary-Tract Infections with a New Antibiotic—Magnamycin , New England J. Med. 248:379-380, 1953. 146. Charet, R., and Siegel, I.: Acute Staphylococcic Lung Abscess Cured with Aid of Bacitracin , A. M. A. Arch. Int. Med. 90:250-257, 1952. 147. Meleney, F. L.; Johnson, B. A., and Teng, P.: Further Experiences with Local and Systemic Bacitracin in the Treatment of Various Surgical and Neurosurgical Infections and Certain Related Medical Infections , Surg., Gynec. & Obst. 94:401-425, 1952. 148. Kagan, B. M.: Antibiotics in Pediatrics , J. M. Soc. New Jersey 49:501-505, 1952. 149. Walker, S. H.: Polymyxin B in Pseudomonas and Proteus Enteritis , J. Pediat. 41:176-181, 1952. 150. Ross, J. V. M.: Polymyxin in Experimental Ocular Pseudomonas Aeruginosa Infections , Am. J. Ophth. 35:82-83, 1952. 151. Jawetz, E.: Infections with Pseudomonas Aeruginosa Treated with Polymyxin B , A. M. A. Arch. Int. Med. 89:90-98, 1952. 152. Wiggins, R. L.: Experimental Studies on the Eye with Polymyxin B , Am. J. Ophth. 35:83-100, 1952. 153. Eareckson, V. O., Jr.; Miller, J. M., and Long, P. H.: Infection of Eye Due to Pseudomonas Aeruginosa Treated with Polymyxin B and "Varidase," A. M. A. Arch. Ophth. 49:158-160, 1953. 154. Cannon, E. J., and Leopold, I. H.: Effectiveness of Terramycin and Other Antibiotics Against Experimental Bacterial Keratitis , A. M. A. Arch. Ophth. 47:426-436, 1952. 155. Flint, M. H.; Gillies, H., and Reid, D. A. C.: Local Use of Chloramphenicol in Wound Infections , Lancet 1:541-545, 1952. 156. Klein, M., and Millwood, E. G.: Chloramphenicol Applied in Calcium Alginate Caps for the Control of Experimental Corneal Infection with Ps. Pyocyanea , Brit. J. Ophth. 36:679-682, 1952. 157. Troen, P., and DiCaprio, J. M.: Pseudomonas Aeruginosa Meningitis: Report of Case Treated with Terramycin , U. S. Armed Forces M. J. 3:1629-1635, 1952. 158. Mitsui, Y.; Tanaka, C., and Hanabusa, J.: Polymyxin in the Treatment of Conjunctivitis Caused by Hemophilus Sp. , Antibiotics & Chemother. 2:501-504, 1952. 159. Longley, J. R., and Thompson, G. J.: Aureomycin in Infections of the Urinary Tract , Minnesota Med. 35:947-948, 1952. 160. Metzger, W. I.; Wright, L. T.; DeLuca, F. R.; Ford, C. E., and Katske, F.: Aureomycin in Urinary Tract Infections , J. Urol. 67:374-389, 1952. 161. Womack, C. R.; Jackson, G. G.; Gocke, T. M.; Kass, E. H.; Haight, T. H., and Finland, M.: Terramycin in Therapy of Urinary Tract Infections , A. M. A. Arch. Int. Med. 89:240-257, 1952.Crossref 162. Scovel, F. G.: Chloramphenicol in Treatment of Typhoid in China , J. A. M. A. 148:1188-1193, 1952.Crossref 163. Corwin, W. C., and Stubbs, S. P.: Further Studies on Tularemia in the Ozarks , J. A. M. A. 149:345-348, 1952.Crossref 164. Arnold, R. C.; Wright, R. D.; Levitan, S., and Cutler, J. C.: Studies in Penicillin Treatment of Syphilis—from 1943-1950 , Pub. Health Rep. 67:78-89, 1952.Crossref 165. O'Brien, J. F.; Rodriquez, J.; Smith, C. A., and Schwemlein, G. X.: Therapy of Early Syphilis with Artificial Fever in Combination with Mapharsen, Bismuth, and Penicillin , Am. J. Syph. 36:451-456, 1952. 166. Shaffer, L. W., and Courville, C. J.: Effectiveness of Penicillin in the Prevention of Congenital Syphilis, with a Note on the Effect of Cowpox Vaccination on the Serologic Tests of Seronegative Infants , Am. J. Syph. 36:457-467, 1952. 167. Tucker, H. A.: Penicillin Treatment of Syphilis , Indian J. Ven. Dis. & Dermat. 18:33-46, 1952. 168. Kolmer, J. A.: Terramycin Hydrochloride Alone and with Mapharsen and Bismuth in Treatment of Experimental Syphilis of Rabbits , Proc. Soc. Exper. Biol. & Med. 79:143-145, 1952. 169. Levaditi, C., and Vaisman, A.: Effets therapeutiques de l'association terramycine-bismuth dans la syphilis expérimentale du lapin , Presse méd. 60:1123-1125, 1952. 170. Robinson, R. C. V.: Newer Antibiotics in the Treatment of Venereal Disease , Brit. J. Ven. Dis. 28:80-88, 1952. 171. Rodriquez, J.; Weinstein, S., and Parkhurst, G. E.: Aureomycin and Its Effect in Early Syphilis: One Year Progress Report , A. M. A. Arch. Dermat. & Syph. 66:59-64, 1952. 172. Willcox, R. R.: Two Cases of Gummatous Ulceration Treated with Terramycin , Brit. J. Ven. Dis. 28:20-23, 1952. 173. Benton, C. D., Jr., and Harris, J. F.: Syphilitic Optic Nerve Atrophy Treated with Penicillin , A. M. A. Arch. Ophth. 48:449-454, 1952. 174. Thomas, E. W.: An Evaluation of the Modern Treatment of Syphilis , Canad. J. Pub. Health 43:47-53, 1952. 175. Robinson, R. C. V.: Syphilitic Interstitial Keratitis After 5 Years of Seronegativity , Am. J. Syph. 36:92-93, 1952. 176. Sorsby, Ungar, and Bailey.30c Andren, S.: Study in the Value of Antibiotic and Chemotherapeutic Agents in Chronic Diseases of the Eye , Acta ophth. 30:281-302, 1952. 177. Pelkonen, U.: On the Administration of Streptomycin and Promizole in Ophthalmic Diseases , Acta ophth. 30:7, 1952. 178. Sykowski, P.: Streptomycin in Miliary Choroidal Tuberculosis , Am. J. Ophth. 35:414-415, 1952 179. Conjunctival Tuberculosis , Sykowski Am. J. Ophth. 35:1824, 1952. 180. Lepri, G., and Capalbi, S.: Influence of Terramycin on the Course of Experimental Ocular Tuberculosis , Brit. J. Ophth. 36:75-80, 1952. 181. Söderholm, B.: Clinical Experiments with Terramycin in the Treatment of Pulmonary Tuberculosis , Acta tuberc. scandinav. 27:109-115, 1952. 182. Fox, H. H.: Chemical Approach to the Control of Tuberculosis , Science 116:129-134, 1952.Crossref 183. Källquist, I.: Late Results of Para-Aminosalicylic Acid Therapy in Secondary Intestinal Tuberculosis , Acta tuberc. scandinav. 27:101-108, 1952. 184. Ross, H. M.: Further Experiences with Para-Aminosalicylic Acid , Canad. M. A. J. 66:353-356, 1952. 185. Shane, S. J.; Laurie, J. H.; Riley, C., and Boutilier, M.: Effect of Combined Therapy (Dihydrostreptomycin and PAS) on the Emergence of Streptomycin-Resistant Strains of Tubercle Bacilli , New England J. Med. 246:132-134, 1952.Crossref 186. Zebrowski, T.; Niepokojczycka, U., and Juchniewicz, M.: Results of Treatment of Pulmonary Tuberculosis with Combined Administration of PAS and Streptomycin , Acta tuberc. scandinav. 26:54-60, 1952. 187. Bavin, E. M., and James, B.: Further Aspects of the Pharmacology of Para-Aminosalicylic Acid , J. Pharm. & Pharmacol. 4:856-871, 1952. 188. Bergqvist, N., and de Mare, O.: Hypothyroidism and Cerebral Edema Following Combined Treatment of Tuberculosis with Conteben (TB I 698) and p-Amino-Salicylic Acid , Acta med. scandinav. 143:323-335, 1952. 189. Hamilton, R. R.: Effect of PAS on the Thyroid Gland , Brit. M. J. 1:29-30, 1953. 190. Carr, D. T.: Current Status of Antimicrobial Therapy in Tuberculosis , J. A. M. A. 150:1170-1173, 1952. 191. Grunberg, E., and Schnitzer, R. J.: Studies on the Activity of Hydrazine Derivatives of Isonicotinic Acid in the Experimental Tuberculosis of Mice , Quart. Bull. Sea View Hosp. 13:3-11, 1952. 192. Robitzek, E. H.; Selikoff, I. J., and Ornstein, G. G.: Chemotherapy of Human Tuberculosis with Hydrazine Derivatives of Isonicotinic Acid , Quart. Bull. Sea View Hosp. 13:27-51, 1952. 193. Selikoff, I. J.; Robitzek, E. H., and Ornstein, G. G.: Toxicity of Hydrazine Derivatives of Isonicotinic Acid in the Chemotherapy of Human Tuberculosis , Quart. Bull. Sea View Hosp. 13:17-26, 1952. 194. Mount, F. W., and Ferebee, S. H.: Control Study of Comparative Efficacy of Isoniazid, Streptomycin-Isoniazid, and Streptomycin-Para-Aminosalicylic Acid in Pulmonary Tuberculosis Therapy: II. Report on 20-Week Observations on 390 Patients with Streptomycin-Susceptible Infections , Am. Rev. Tuberc. 67:108-113, 1953. 195. Treatment of Pulmonary Tuberculosis with Isoniazid: An Interim Report to the Medical Research Council Investigation by Their Tuberculosis Chemotherapy Trials Committee , Brit. M. J. 2:735-746, 1952. 196. Thoren, M., and Hinshaw, H. C.: Therapy of Pulmonary Tuberculosis with Isoniazid Alone and in Combination with Streptomycin and with Para-Amino-Salicylic Acid , Stanford M. Bull. 10:316-318, 1952. 197. Fusillo, M. H.; Wagner, B. M., and Kuhns, D. M.: Relationship of Streptomycin Sensitivity of M. Tuberculosis to the Action of Hydrazines of Isonicotinic Acid (Rimifon and Marsalid) , Antibiotics & Chemother. 2:484-486, 1952. 198. Bernstein, J.; Jambar, W. P.; Lott, W. A.; Pansy, F.; Steinberg, B. A., and Yale, H. L.: Chemotherapy of Experimental Tuberculosis: VI. Derivatives of Isoniazid , Am. Rev. Tuberc. 67:354-365, 1953. 199. Pansy, F.; Stander, H., and Donovick, R.: In Vitro Studies on Isonicotinic Acid Hydrazide , Am. Rev. Tuberc. 65:761-764, 1952. 200. Hobby, G. L., and Lenert, T. F.: Resistance to Isonicotinic Acid Hydrazid , Am. Rev. Tuberc. 65:771-774, 1952. 201. Karlson, A. G., and Ikemi, Y.: Occurrence of Human-Type Tubercle Bacilli (H37Rv) Resistant to Isonicotinic Acid Hydrazide in a Culture Not Previously Exposed to the Drug , Proc. Staff Meet., Mayo Clin. 27:239-240, 1952. 202. Aronson, J. D.; Ehrlich, S. L., and Flagg, W.: Effects of Isonicotinic Acid Derivatives on Tubercle Bacilli , Proc. Soc. Exper. Biol. & Med. 80:259, 1952. 203. Jordan, J. W.: Cutaneous Allergy from Local Contact with Isonicotinic Acid Hydrazid , J. A. M. A. 149:1316-1317, 1952. 204. Linton, W. S.; Rabinovitz, E., and Olie, M.: Isonicotinic Acid Hydrazide: Some Sensory Disturbances During Therapy , South African M. J. 26:889-890, 1952. 205. Selikoff, I. J.; Robitzek, E. H., and Ornstein, G. G.: Withdrawal Symptoms upon Discontinuance of Iproniazid and Isoniazid Therapy , Am. Rev. Tuberc. 67:212-216, 1953. 206. Selikoff, I. J., and Robitzek, E. H.: Tuberculous Chemotherapy with Hydrazine Derivatives of Isonicotinic Acid , Dis. Chest 21:385-438, 1952. 207. Lattimer, J. K.: Caution Necessary in the Treatment of Renal Tuberculosis with Isoniazid , J. A. M. A. 150:981-983, 1952. 208. Dye, W. E.; Lynch, H. P., and Brees, A. G.: Incidence of Bacterial Resistance Encountered with Tuberculosis Chemotherapy Regimens Employing Isoniazid Alone and in Combination with Intermittent Streptomycin , Am. Rev. Tuberc. 67:106-107, 1953. 209. Ilavsky, J.: Synergistic Action of Isonicotinic Acid Hydrazide and Streptomycin in Vitro , Am. Rev. Tuberc. 65:777-778, 1952. 210. Paraf, J.; Desbordes, J., and Rosenberg, E.: Action synergique de l'acide para-aminosalicylique et des dérivés iso-nicotiniques dans la tuberculose expérimentale du cobaye , Comp. rend. Soc. biol. 146:1518-1521, 1952. 211. Pitts, F. W.; Miller, F. L.; Dye, W. E.; Tempel, C. W., and Fitzpatrick, M. J.: Isoniazid Therapy in Pulmonary Tuberculosis: A Preliminary Report , U. S. Armed Forces M. J. 4:1-9, 1953. 212. Witkind, E.; Willner, I., and Brandman, O.: Isonicotinic Acid in Tuberculosis—Preliminary Report: Clinical Experiences , J. M. Soc. New Jersey 49:340-342, 1952. 213. Karp, A., and Snyder, J. C.: In Vitro Effect of Aureomycin, Terramycin, and Chloramphenicol on Typhus Rickettsiae , Proc. Soc. Exper. Biol. & Med. 79:216-219, 1952. 214. Armstrong, T. G.; Wilmot, A. J., and Elsdon-Dew, R.: Terramycin in the Treatment of Amoebic Dysentery , South African M. J. 26:766-768, 1952. 215. Darrow, E. M.; Gingrich, W. D., and Prene, J. H.: Effect of Antibiotics on Experimental Malaria (Plasmodium cathemerium and Plasmodium berghei) , Am. J. Trop. Med. 1:917-927, 1952. 216. Grassi, C., and Kass, E.: Failure of Terramycin Treatment in Acute Experimental Toxoplasmosis , Acta path. et microbiol. scandinav. 30:304-305, 1952. 217. Neghme, A.; Agosin, M.; Christen, R., and Rubio, M.: In Vitro Action of Aureomycin and Terramycin on Balantidium Coli , Exper. Parasit. 1:189-195, 1952. 218. Ruiz-Sanchez, F.; Quezada, M.; Paredes, M.; Casillas, J., and Riebeling, R.: Chloramphenicol in Malaria , Am. J. Trop. Med. 1:936-940, 1952. 219. Ruiz-Sanchez, F.; Casillas, J.; Paredes, M.; Velazquez, J., and Riebeling, R.: Terramycin in the Treatment of Malaria , Antibiotics & Chemother. 2:51-57, 1952. 220. Cabasso, V. J.; Moore, I. F., and Cox, H. R.: In Vitro and in Vivo Action of Aureomycin on Vaccinia Virus in the Chick Embryo and in the Rabbit , J. Infect. Dis. 91:79-85, 1952. 221. Colbert, J. W., Jr.; Bungards, L., and Knowlton, M.: Aureomycin, Chloromycetin, and Terramycin in Treatment of Acute Viral Hepatitis , Proc. Soc. Exper. Biol. & Med. 79:339-343, 1952. 222. Fagan, R.: Ineffectiveness of Aureomycin and Terramycin Against Rabies Street Virus in Mice , Proc. Soc. Exper. Biol. & Med. 81:213-214, 1952. 223. Finland, M.: Antimicrobial Treatment for Viral and Related Infections: II. Antibiotic Treatment of Acute Respiratory Infections and Influenza , New England J. Med. 247:557-567, 1952. 224. Haseeb, M. A.: Terramycin in the Treatment of Experimental Rabies in Mice , Nature, London 170:983, 1952. 225. Homer, L., and Donovan, W. N.: Aureomycin in Mumps , J. A. M. A. 150:465-467, 1952. 226. Homer, L.; Donovan, W. N., and Radke, R. A.: Effect of Antibiotics in Abacterial Pneumonia , U. S. Armed Forces M. J. 3:1767-1775, 1952. 227. Frampton, G., and Smith, C.: Primary Vaccinia of the Eyelid , Brit. J. Ophth. 36:214-216, 1952. 228. Kass, E. H.; Aycock, R. R., and Finland, M.: Clinical Evaluation of Aureomycin and Chloramphenicol in Herpes Zoster , New England J. Med. 246:167-172, 1952. 229. Schaffer, G., and Svendsen, B.: Aureomycin and Chloromycetin in the Treatment of Herpes Zoster , Acta dermat.-venereol. 32:184-190, 1952. 230. Bedson, S. P.: Recent Work on the Viruses of the Psittacosis-Lymphogranuloma Group and Its Importance with Special Reference to Primary Atypical Pneumonia , Irish J. M. Sc. 6:385-397, 1952. 231. Cat, N. D.: Comments on the Treatment of Trachoma with Aureomycin , Am. J. Trop. Med. 1:796-798, 1952 232. Terramycin in the Treatment of Trachoma , Cat Am. J. Trop. Med. 1:799-808, 1952 233. Essai de traitement du trachome par la terramycine , Presse méd. 60:643-644, 1952. 234. Diab, A. E., and Abu-Jaudeh, C. N.: Aureomycin in Trachoma , Am. J. Ophth. 35:1187-1190, 1952 235. The Sulfonamides in Trachoma , Diab Am. J. Ophth. 35:1339-1342, 1952. 236. Siniscal, A. A.: The Sulfonamides and Antibiotics in Trachoma , Am. J. Ophth. 35:671-682, 1952 237. Sulfonamides and Antibiotics in Trachoma , J. A. M. A. 148:637-639, 1952. 238. Makari, J. G.: Benadryl and Sulfadiazine in the Treatment of Trachoma , J. Trop. Med. 55:263-265, 1952. 239. Garrod, L. P.: Sensitivity of Actinomyces Israeli to Antibiotics , Brit. M. J. 1:1263-1264, 1952. 240. Glahn, M.: Treatment of Cervico-Facial Actinomycosis with Special Regard to Penicillin Therapy , Acta chir. scandinav. 102:443-446, 1952. 241. Klinger, P.: Management of Actinomycosis , M. Bull., Chief Surgeon, European Command 9:360-365, 1952. 242. Littman, M. L.; Paul, J. S., and Fusillo, M. H.: Treatment of Pulmonary Actinomycosis with Chloramphenicol , J. A. M. A. 148:608-812, 1952.Crossref 243. Florestano, H. J., and Bahler, M. E.: Antifungal Properties of the Polymyxins , Proc. Soc. Exper. Biol. & Med. 79:141-143, 1952. 244. Franks, A. G.: Tinea Capitis Treated with Thiolutin , J. Invest. Dermat. 19:269, 1952. 245. Hickey, R. J.; Corum, C. J.; Hidy, P. H.; Cohen, I. R.; Nager, U. F. B., and Kropp, E.: Ascosin, an Antifungal Antibotic Produced by a Streptomycete , Antibiotics & Chemother. 2:472-483, 1952. 246. Seneca, H.; Kane, J. H., and Rockenbach, J.: Bacterial, Protozoicidal and Fungicidal Properties of Thiolutin , Antibiotics & Chemother. 2:357-360, 1952. 247. Waksman, S. A.; Romano, A. H.; Lechevallier, H., and Raubitschek, F.: Antifungal Antibiotics , Bull. World Health Organ. 6: 163-172, 1952. 248. Birge, H. L.: Ocular Aspects of Mycotic Infection , A. M. A. Arch. Ophth. 47:354, 1952. 249. Gastineau, F. M., and Florestano, H. J.: Clinical Experience with "Polycin," a Polymyxin-Bacitracin Ointment , A. M. A. Arch. Dermat. & Syph. 66:70-75, 1952. 250. Shlaes, W. H.; Volini, I. F.; Felsenfeld, O., and Burbidge, E.: The Antibacterial Action of Combinations of Penicillin and Sulfonamides: I. Laboratory Studies , Antibiotics & Chemother. 2:21-24, 1952 251. The Antibacterial Action of Combinations of Penicillin and Sulfonamides: II. Clinical Observations , Shlaes Antibiotics & Chemother. 2:25-29, 1952. 252. Weinstein, L., and Murphy, E. B.: Comparison of Antibacterial Activity of Single and Combined Sulfonamides , Proc. Soc. Exper. Biol. & Med. 80:519, 1952. 253. Speck, R. S., and Jawetz, E.: Antibiotic Synergism and Antagonism in a Subacute Experimental Streptococcus Infection in Mice , Am. J. M. Sc. 223:280-285, 1952. 254. Ahern, H. G.; Hirshfeld, A., and Sobel, A. E.: Lack of Interference of Chloramphenicol with Penicillin in a Hemolytic Streptococcal Infection in Mice , Proc. Soc. Exper. Biol. & Med. 79:668, 1952. 255. Neter, E.; Kunz, E. H., and Morgan, E. D.: Synergistic Effects of Polymyxin B and Terramycin on Urinary Tract Infections , J. Urol. 67:773, 1952. 256. Pomerantz, H. Z.: Combined Antibiotic Therapy , Canad. M. A. J. 66:424-425, 1952. 257. Waisbren, B. A.: Penicillin and Chloramphenicol in the Treatment of Infections Due to Proteus Organisms , Am. J. M. Sc. 223:418-421, 1952. 258. Jawetz, E., and Gunnison, J. B.: Studies on Antibiotic Synergism and Antagonism: A Scheme of Combined Antibiotic Action , Antibiotics & Chemother. 2:243-248, 1952. 259. Jawetz, E.: Antibiotic Synergism and Antagonism , A. M. A. Arch. Int. Med. 90:301-319, 1952. 260. Jawetz, E., and Gunnison, J. B.: An Experimental Basis of Combined Antibiotic Action , J. A. M. A. 150:693-695, 1952. 261. Yall, I., and Green, M. N.: Sulfhydryl Variation in Bacterial Enzymes in Relationship to Chemotherapy with the Nitro-Furans , Proc. Soc. Exper. Biol. & Med. 79:306-308, 1952. 262. Asnis, R. E.; Cohen, F. B., and Gots, J. S.: Studies on Bacterial Resistance to Furacin , Antibiotics & Chemother. 2:123-129, 1952. 263. Paul, H. E.; Harrington, C. M.; Bender, R. C., and Briggs, W. P.: Resistance and Cross Resistance of Bacteria to Nitrofurans , Proc. Soc. Exper. Biol. & Med. 79:199-204, 1952. 264. Brennan, J. W.: Use of Furacin in Ophthalmology , Am. J. Ophth. 35:1343-1345, 1952. 265. Heseltine, W. W.: Sodium Propionate and Its Derivatives as Bacteriostatics and Fungistatics , J. Pharm. & Pharmacol. 4:577-581, 1952. 266. Heseltine, W. W.: A Note on Sodium Propionate , J. Pharm. & Pharmacol. 4:120-122, 1952. 267. Prophylaxis of Ophthalmia Neonatorum, Editorial , J. A. M. A. 148:122-123, 1952. 268. Elliott, R. A.: Ophthalmia Neonatorum: A Review of Prophylactic Methods at Present in Use , Month. Bull. Min. Health 11:135-137, 1952. 269. Eaton, M. D.; Levenson, C. G., and Perry, M. E.: Inhibition of the Growth of Viruses in the Chick Embryo by Aromatic Diamidines , J. Immunol. 68:1-9, 1952. 270. Eaton, M. D.; Perry, M. E.; Levenson, C. E., and Gocke, I. M.: Studies on the Mode of Action of Aromatic Diamidines on Influenza and Mumps Virus in Tissue Culture , J. Immunol. 68:321-334, 1952. 271. Heilman, F. R.: Effect of Stilbamidine on Blastomycosis in Mice , Proc. Staff Meet., Mayo Clinic 27:455-458, 1952. 272. Miller, J. M.; Schoenbach, E. B.; Long, P. H.; Shuttleworth, J. S., and Snider, G. E.: Treatment of Infections Due to Cryptococcus Neoformans with Stilbamidine , Antibiotics & Chemother. 2:444-446, 1952. 273. Miller, J. M.; Long, P. H., and Schoenbach, E. B.: Successful Treatment of Actinomycosis with "Stilbamidine," J. A. M. A. 150:35, 1952. 274. Schoenbach, E. B.: Use of the Aromatic Diamidines for the Treatment of Systemic Fungal Disease , Tr. New York Acad. Sc. 14:272-273, 1952. 275. Snapper, I.; Schneid, B.; McVay, L., and Lieben, F.: Pharmacology and Therapeutic Value of Diamidine Derivatives—Particularly 2-Hydroxystilbamidine , Tr. New York Acad. Sc. 14:269, 1952. 276. Thorn, G. W.: The Adrenals in Health and Disease , Tr. & Stud. Coll. Physicians Philadelphia 19:95-113, 1952. 277. Thorn, G. W.; Jenkins, D.; Laidlaw, J. C.; Goetz, F. C.; Dingman, J. F.; Arons, W. L.; Streeten, D. H. P., and McCracken, B. H.: Medical Progress: Pharmacologic Aspects of Adrenocortical Steroids and ACTH in Man , New England J. Med. 248:232, 284-294, 323-337, 369-378 and 414-423, 1953. 278. Berens, C., and Bickerton, J. H.: Review of the Results of Cortisone and ACTH Therapy in Diseases of the Eye , Quart. Rev. Ophth. 8:77-86, 1952. 279. Ingle, D. J., and Li, C. H.: Comparison of Biologic Effects of ACTH Protein and ACTH Peptide Given by Continuous Injection , Proc. Soc. Exper. Biol. & Med. 79:128-131, 1952. 280. Pincus, G.; Hopkins, T. F., and Hechter, O.: An ACTH-Inactivating Factor in Mammalian Blood , Arch. Biochem. 37:408-418, 1952. 281. Haynes, R.; Savard, K., and Dorfman, R. I.: An Action of ACTH on Adrenal Slices , Science 116:690-691, 1952.Crossref 282. Pfiffner, J. J.: Adrenal Cortical Hormones , Advances Enzymol. 2:325-356, 1942. 283. Nelson, D. H., and Samuels, L. T.: Method for Determination of 17-Hydroxycorticosteroids in Blood: 17-Hydroxycorticosterone in the Peripheral Circulation , J. Clin. Endocrinol. 12:519-526, 1952.Crossref 284. Kinsell, L. W.; Michaels, G. D.; Margen, S.; Boling, L., and Partridge, J. W.: Evidence for Acceleration of Neoglucogenesis from Fat by ACTH, Cortisone and Related Compounds , J. Clin. Endocrinol. 12:945, 1952. 285. Hills, O. W.; Power, M. H., and Wilder, R. M.: Diabetes Mellitus and Cushing's Syndrome , Diabetes 1:351-357, 1952. 286. Appel, S. B., and Orr, K. D.: Observations on Essentially Normal Young Men Treated with ACTH and Cortisone: I. Effects on Glucose Metabolism , U. S. Armed Forces M. J. 3:207-219, 1952. 287. Bookman, J. J.; Drachman, S. R.; Schaefer, L. E., and Adlersberg, D.: Studies on Steroid Diabetes in Man , J. Clin. Endocrinol. 12:945-946, 1952. 288. Jackson, R. S., and Fabrykant, M.: Early Effects of ACTH on Arterial and Venous Blood Glucose and on Renal Glucose Excretion , Am. J. Digest. Dis. 19:329-332, 1952.Crossref 289. Dana, G.; Eversole, S., and Zubrod, C.: Clinical Entity of Retinal Aneurysms, Glomerular Nodules and Hyperglycemia , Bull. Johns Hopkins Hosp. 90:323-326, 1952. 290. Becker, B.: Diabetic Retinopathy , Ann. Int. Med. 37:273-289, 1952.Crossref 291. Friedenwald, J. S.: Diabetic Retinopathy , J. A. M. A. 150:969-971, 1952.Crossref 292. Engel, F. L.: On the Nature of the Interdependence of the Adrenal Cortex, Non-Specific Stress and Nutrition in the Regulation of Nitrogen Metabolism , Endocrinology 50: 462-477, 1952.Crossref 293. Morrison, J. F.: Effect of Adrenocorticotrophic Hormone and Growth Hormone on the Fat, Water and Protein Content of Mouse Liver , Australian J. Exper. Biol. & M. Sc. 30:313-317, 1952. 294. Etheridge, E. M., and Hoch-Ligeti, C.: Lipid Deposition in Aortas in Younger Age Groups Following Cortisone and Adrenocorticotrophic Hormone , Am. J. Path. 28:315-318, 1952. 295. Bloom, B., and Pierce, F. T., Jr.: Relationship of ACTH and Cortisone to Serum Lipoproteins and Atherosclerosis in Humans , Metabolism 1:155-171, 1952. 296. Farah, A. E.: Effects of Desoxycorticosterone and Adrenocorticotrophic Hormone on Mercurial Diuresis , Proc. Soc. Exper. Biol. & Med. 80:295, 1952. 297. Glafkides, C. M.; Bennett, L. L., and George, G. R.: Inhibition of the Diabetes Enhancing Effect of ACTH by a Diet High in Potassium Chloride , Endocrinology 50:684-686, 1952. 298. Whitney, J. E., and Bennett, L. L.: Inhibition of the Catabolic Effect of Adrenocorticotrophic Hormone (ACTH) in Rats by a Diet High in Potassium Chloride , Endocrinology 50:657-663, 1952. 299. Aikawa, J. K.: Effects of Cortisone Acetate on Fluid and Electrolyte Balance in Normal Rabbits , Proc. Soc. Exper. Biol. & Med. 82:105-109, 1953. 300. Friis-Hansen, B.; Tudvad, F., and Vesterdal, J.: Effect of ACTH on Body Water Compartment in Juvenile Rheumatoid Arthritis , Scandinav. J. Clin. Lab. Invest. 4:36-42, 1952. 301. Sirek, O. V., and Best, C. H.: Intramuscular Cortisone Administration to Dogs , Proc. Soc. Exper. Biol. & Med. 80:594-598, 1952. 302. Jailer, J. W.; Louchart, J., and Cahill, G. F.: Diagnostic Considerations and Treatment in Adrenal Virilism , J. A. M. A. 150:575-579, 1952. 303. Fraser, C. G.; Preuss, F. S., and Bigford, W. D.: Adrenal Atrophy and Irreversible Shock Associated with Cortisone Therapy , J. A. M. A. 149:1542-1543, 1952. 304. Hungerford, G. F.; Reinhardt, W. O., and Li, C. H.: Lack of Correlation of Eosinopenic and Adrenal Ascorbic Acid-Depleting Activities of Various Adrenocorticotropic Preparations , Proc. Soc. Exper. Biol. & Med. 81:320, 1952. 305. Bacchus, H.; Heiffer, M. H., and Altszuler, N.: Potentiating Effect of Ascorbic Acid on Cortisone-Induced Gluconeogenesis , Proc. Soc. Exper. Biol. & Med. 79:648-650, 1952. 306. Bacchus, H.; Altszuler, N., and Heiffer, M. H.: Prolongation of Effects of Adrenal Cortical Secretion by Ascorbic Acid: Proposed Mechanism of Action , Proc. Soc. Exper. Biol. & Med. 80:88-91, 1952. 307. Booker, W. M.; Johnson, J. B.; Hayes, R. L.; Thomas, R. F.; Henry, W.; Tureman, J. R., and Bent, F.: Effect of Cortisone on Tolerance to Ascorbic Acid and Level of Blood Cholesterol in Man , J. Clin. Endocrinol. 12:346-353, 1952. 308. DesMarais, A., and Leblanc, J.: "In Vivo" and "In Vitro" Effect of Ascorbic Acid and ACTH on the Rat Adrenal Cortex , Canad. J. M. Sc. 30:157-172, 1952. 309. Hughes, C. D.; Swenson, M. J.; Underbjerg, G. K. L., and Hughes, J. S.: Function of Vitamin C in the Adrenal Cortex , Science 116:252-253, 1952. 310. Stewart, C. P.; Horn, D., and Robson, J. S.: Effect of Cortisone and Adrenocorticotropic Hormone on the Dehydroascorbic Acid of Human Blood Plasma , Biochem. J. 51:xx, 1952. 311. Banerjee, S., and Chandicharan, D.: Adrenal Cortical Activity in Scurvy , Endocrin ology 51:572-576, 1952. 312. Herrick, E. H.; Mead, E. R.; Egerton, B. W., and Hughes, J. S.: Some Effects of Cortisone on Vitamin C-Deficient Guinea Pigs , Endocrin 50:259-263, 1952. 313. Stewart, C. T.; Salmon, R. J., and May, C. D.: Function of the Adrenal Cortex in Ascorbic Acid Deficiency and Scurvy in the Monkey , J. Lab. & Clin. Med. 40:657-663, 1952. 314. Fredickson, D. S.; Forshan, P. H., and Thorn, G. W.: Effect of Massive Cortisone Therapy on Measurements of Thyroid Function , J. Clin. Endocrin. 12:541-553, 1952. 315. Albert, A.; Tenney, A., and Ford, E.: Effect of Cortisone and Corticotropin on the Biologic Decay of Thyroidal Radio Iodine , Endocrinology 50:324-326, 1952. 316. Epstein, D.; Cantarow, A.; Friedler, G., and Paschkis, K. E.: Inhibition of Thyroid Function by Cortisone and ACTH in Hypophysectomized Rats , Proc. Soc. Exper. Biol. & Med. 82:50, 1953. 317. Halmi, N. S.: Cortisone and Action of Exogenous Thyrotrophin in Hypophysectomized Rats , Proc. Soc. Exper. Biol. & Med. 80:175-176, 1952. 318. Albert, A.; Tenney, A., and Lorenz, N.: Effect of Hypophysectomy on the Renal Clearance of I131 , Endocrinology 50:327-330, 1952. 319. Berson, S. A., and Yalow, R. S.: Effect of Cortisone on the Iodine Accumulating Function of the Thyroid Gland in Euthyroid Subjects , J. Clin. Endocrinol. 12:407-422, 1952. 320. Kuhl, W. J., Jr., and Ziff, M.: Alteration of Thyroid Function by ACTH and Cortisone , J. Clin. Endocrinol. 12:554-559, 1952. 321. Dayton, G. O., Jr.: Effect of ACTH on Experimental Exophthalmos , Am. J. Ophth. 35:101-106, 1952. 322. Hanser, S. A.; Moor, W. A., and Stickle, A. W.: Cytology of Allergic Conjunctivitis , A. M. A. Arch. Ophth. 47:728-733, 1952.Crossref 323. Krebs, G. C., and Holmes, J. H.: The Thorn Test During Cortisone Therapy , Rocky Mountain M. J. 49:40-43, 1952. 324. Andersson, E.: Effect of ACTH on the Eosinophils in Blood and Bone Marrow , Acta allergol. 5:52-57, 1952.Crossref 325. Padawer, J., and Gordon, A. S.: A Mechanism for the Eosinopenia Induced by Cortisone and by Epinephrine , Endocrinology 51:52, 1952.Crossref 326. Henderson, L. L., and Thompson, E. C.: Corticotropin in Eosinophilic Granuloma , J. A. M. A. 151:294-295, 1953.Crossref 327. Halberg, F.: Some Correlations Between Chemical Structure and Maximal Eosinopenia in Adrenalectomized and Hypophysectomized Mice , J. Pharmacol. & Exper. Therap. 106:135-140, 1952. 328. Dougherty, T. F.: Effect of Hormones on Lymphatic Tissue , Physiol. Rev. 32:379-401, 1952. 329. Frank, J. A., and Dougherty, T. F.: Cytoplasmic Budding of Human Lymphocytes Produced by Cortisone and Hydrocortisone in in Vitro Preparations , Proc. Soc. Exper. Biol. & Med. 82:17-19, 1953. 330. Hudson, G.; Herdan, G., and Yoffey, J. M.: Effect of Repeated Injections of ACTH upon the Bone Marrow , Brit. M. J. 1:999-1002, 1952. 331. Burkell, C. C.: Radiation Leukopenia and Cortisone , J. Canad. A. Radiologists 3:30, 1952. 332. Thiersch, J. B.; Conroy, L.; Stevens, A. R., and Finch, C. A.: Adverse Effect of Cortisone on Marrow Regeneration Following Irradiation , J. Lab. & Clin. Med. 40:174-181, 1952. 333. Jacobson, B. M., and Sohier, W. D.: Effects of ACTH and of Cortisone on the Platelets in Idiopathic Thrombopenic Purpura , New England J. Med. 246:247-249, 1952. 334. Stefanini, M.; Santiago, E. P.; Chatterjea, J. B.; Dameshek, W., and Salomon, L.: Corticotropin (ACTH) and Cortisone in Idiopathic Thrombocytopenia Purpura , J. A. M. A. 149:647-653, 1952. 335. Studer V. A., and Frey, J. R.: Wirkung von Cortison auf die ruhende und die mit Vitamin A oder Testosteronpropionat zur Proliferation gebrachte Epidermis der Ratte , Dermatologica 104:1-18, 1952. 336. Lattes, R.; Blunt, J. W.; Rose, H. M.; Jessar, R. A.; Vaillancourt, de G., and Ragan, C.: Lack of Cortisone Effect in the Early Stages of Inflammation and Repair , Am. J. Path. 29:1-19, 1953. 337. Spain, D. M., and Molomut, N.: Effect of Cortisone in Inflammation in Mice , Am. J. Clin. Path. 22:944-947, 1952. 338. Rubin, A., and Lischner, M. D.: Effect of Premedication of Cortisone on the Healing of Wounds in an Infant , Connecticut M. J. 16:682-683, 1952. 339. Baker, R.; Govan, D., and Huffer, J.: Inhibitory Effect of Cortisone on Strictures of the Urological Tract , Surg., Gynec. & Obst. 95:446-454, 1952. 340. Carstam, N.: Prevention of Experimental Tendon Adhesions by Cortisone , Acta orthop. scandinav. 22:15-24, 1952. 341. Taylor, F. W.; Dittmer, T. L., and Porter, D. O.: Wound Healing and the Steroids , Surgery 31:683-690, 1952. 342. Findlay, C. W., and Howes, E. L.: Combined Effect of Cortisone and Partial Protein Depletion on Wound Healing , New England J. Med. 246:597-604, 1952.Crossref 343. James, W. M.; Power, J. L., and Ripple, P. H.: Experimental and Clinical Observations of the Effects of Cortisone in Corneal Lesions , Am. J. Ophth. 35:1298-1304, 1952 344. Laval, J., and Coles, R. S.: Role of Cortisone in Glaucoma Surgery , A. M. A. Arch. of Ophth. 49:168-181, 1953.Crossref 345. Moon, V. H., and Tershakovec, G. A.: Influence of Cortisone upon Acute Inflammation , Proc. Soc. Exper. Biol. & Med. 79:63-65, 1952. 346. Spain, D. M.; Molomut, N., and Haber, A.: Studies of the Cortisone Effects on the Inflammatory Response: I. Alterations of the Histopathology of Chemically Induced Inflammation , J. Lab. & Clin. Med. 39:383-389, 1952. 347. Curran, R. C.: Effect of Cortisone on the Reaction of the Mouse Peritoneum to Quartz , Brit. J. Exper. Path. 33:82-86, 1952. 348. Harrison, C. V.; King, E. J.; Dale, J. C., and Sichel, R.: Effect of Cortisone on Experimental Silicosis , Brit. J. Indust. Med. 9:165-172, 1952. 349. Menkin, V.: Localization of Cortisone in an Inflamed Area , Federation Proc. 11:106, 1952. 350. Soskin, S.: Physiologic Basis for the Therapeutic Effects of Cortisone , Rev. Gastroenterol. 19:808-816, 1952. 351. Gubner, R.; Cote, L.; Hughes, J.; Oleson, J. J.; Ruegsegger, J. M., and Williams, J. H.: Comparative Effects of Aminopterin, Cortisone and ACTH in Experimental Formaldehyde Arthritis and Psoriatic Arthritis , J. Invest. Dermat. 19:297-305, 1952. 352. Leopold, I. H., and Maylath, F. R.: Intraocular Penetration of Cortisone and Its Effectiveness Against Experimental Corneal Burns , Am. J. Ophth. 35:1125-1134, 1952 353. Michaelson, I. C., and Haifa, I.: Effect of Cortisone upon Corneal Vascularization Produced Experimentally , A. M. A. Arch. Ophth. 47:459-464, 1952. 354. Woods, A. C., and Wood, R. M.: Effect of Cortisone and ACTH on Ocular Inflammation Secondary to the Injection of Irritant Substances , Bull. Johns Hopkins Hosp. 90:134-148, 1952. 355. Sheppard, L. B.: Comparative Effects of Cortisone on Rabbit Eyes Treated by Cyclodiathermy and Cyclo-Electrolysis , Am. J. Ophth. 36:193-203, 1953. 356. Mogabgab, W. J., and Thomas, L., Jr.: Effects of Cortisone on Bacterial Infections: Group A Hemolytic Streptococcal Infection in Rabbits , J. Lab. & Clin. Med. 39:271-289, 1952. 357. DeLamater, E. D.; Saurino, V. R., and Urbach, F.: Studies on the Immunology of Spirochetoses: I. Effect of Cortisone on Experimental Spirochetosis , Am. J. Syph. 36:127-139, 1952. 358. Germuth, F. G., Jr.; Ottinger, B., and Oyama, J.: Influence of Cortisone on the Evolution of Acute Infection and the Development of Immunity , Bull. Johns Hopkins Hosp. 91:22-48, 1952. 359. Antopol, W., and Quittner, H.: The Changing Pattern of Infectious Processes Under the Influence of Cortisone , J. Mt. Sinai Hosp. 19:91-105, 1952. 360. Cook, C., and Smith, C.: Sepsis and Cortisone , Nature, London 170:980, 1952. 361. Molomut, N., and Spain, D. M.: Effect of a Minimal Dose of Cortisone Combined with a Subeffective Dose of Dihydrostreptomycin on Experimental Guinea Pig Tuberculosis , Am. Rev. Tuberc. 67:101-102, 1953. 362. Engbaek, H. C.; Friis, T., and Theilum, G.: Effect of Cortisone on the Tuberculous Infection in Mice and Guinea Pigs , Acta path. et microbiol. scandinav. 31:317-324, 1952.Crossref 363. Cummings, M. M.; Hudgins, P. C.; Whorton, M. C., and Sheldon, W. H.: Influence of Cortisone and Streptomycin on Experimental Tuberculosis in the Albino Rats , Am. Rev. Tuberc. 65:596-602, 1952. 364. Winner, H. I., and Evans, W. E. D.: Experimental Tuberculosis in Cortisone-Treated Guinea Pigs , Tubercle 33:239-242, 1952.Crossref 365. Bacos, J. M., and Smith, D. T.: Effect of Corticotropin (ACTH), Dihydrostreptomycin, and Corticotropin-Dihydrostreptomycin on Experimental Bovine Tuberculosis in the Rabbit , Am. Rev. Tuberc. 67:201-211, 1953. 366. Karlson, A. G., and Gainer, J. H.: Failure of Cortisone to Affect the Therapeutic Activity of Streptomycin in Experimental Tuberculosis of Guinea Pigs , Proc. Staff Meet., Mayo Clin. 27:465-471, 1952. 367. Ebert, R. H.: In Vivo Observations on the Effect of Cortisone on Experimental Tuberculosis, Using the Rabbit Ear Chamber Technique , Am. Rev. Tuberc. 65:64-74, 1952. 368. Woods, A. C., and Wood, R. M.: Studies in Experimental Ocular Tuberculosis , A. M. A. Arch. Ophth. 47:477-512, 1952.Crossref 369. Findlay, G. M., and Howard, E. M.: Effects of Cortisone and Adrenocorticotrophic Hormone on Poliomyelitis and on Other Virus Infections , J. Pharm. & Pharmacol , 4:37-42, 1952. 370. Shwartzman, G., and Fisher, A.: Alteration of Experimental Poliomyelitis Infection in the Syrian Hamster with the Aid of Cortisone , J. Exper. Med. 95:347-362, 1952. 371. Braley, A. E.: Experimental Herpes Simplex , Am. J. Ophth. 35:1737-1747, 1952. 372. Berens, C.; Sayad, W. Y., and Girard, L. J.: Symposium: Ocular Allergy: I. The Uveal Tract and Retina; Consideration of Certain Experimental and Clinical Concepts , Tr. Am. Acad. Ophth , 56:220-241, 1952. 373. Castroviejo, R.: Symposium: Ocular Allergy: II. Cornea and Lens , Tr. Am. Acad. Ophth 56:242, 1952. 374. Hanser, S. A.: Symposium: Ocular Allergy: III. External Eye and Aqueous , Tr. Am. Acad. Ophth 56:256, 1952. 375. Brown, E. A.: ACTH and Allergy , Ann. Allergy 10:356-391, 1952. 376. Evans, R. R., and Rackermann, F. M.: Allergy—Corticotropin and Cortisone , A. M. A. Arch. Int. Med. 90:96-127, 1952. 377. Hayes, S. P., and Dougherty, T. F.: Effect of ACTH and Cortisone on Antibody Synthesis and Rate of Disappearance of Antigen , Federation Proc. 11:67, 1952. 378. Clayton, B. E.; Hardisty, R. M., and Pinniger, J. L.: Studies on Antibody Formation to ACTH in Man , J. Endocrinol. 8:56-63, 1952. 379. Hunter, O. B., Jr., and Ross, J. B.: Cortisone in Rh Incompatibilities , South. M. J. 45:732-738, 1952. 380. Agosin, M.; Christen, R.; Badinez, O.; Gasic, G.; Neghme, A.; Pizzaro, O., and Jarpa, A.: Cortisone-Induced Metastases of Adenocarcinoma in Mice , Proc. Soc. Exper. Biol. & Med. 80:128-131, 1952. 381. Foley, E. J.: Effect of Cortisone Acetate on Growth of Strain Specific Tumors in Alien Strains of Mice , Agosin Proc. Soc. Exper. Biol. & Med. 80:669-671, 1952. 382. Green, H. N., and Whiteley, H. J.: Cortisone and Tumor Growth , Brit. M. J. 2:538-540, 1952. 383. Andersson, E.: Adrenocorticotropic Hormone (ACTH) and Cortisone: Their Effect on Intradermal Reactions , Acta allergol. 5:58-71, 1952. 384. Germuth, F. G., Jr.; Ottinger, B., and Oyama, J.: Influence of Cortisone on Experimental Hypersensitivity and Circulating Antibody in the Guinea Pig , Proc. Soc. Exper. Biol. & Med. 80:188, 1952. 385. Jeter, W. S., and Seebohm, P. M.: Effect of Cortisone and Adrenocorticotropic Hormone on Delayed Hypersensitivity to 2,4-Dinitrochlorobenzene in Guinea Pigs , Proc. Soc. Exper. Biol. & Med. 80:694, 1952. 386. Grob, D.; Winkenwerder, W. L., and Schoenrich, E. H.: Effect of the Adrenocorticotropic Hormone (ACTH) Administration on Skin, Conjunctival and Nasal Mucous Membrane Reactivity to Histamine and Antigens in Man , Bull. Johns Hopkins Hosp. 90:301-312, 1952. 387. Halpern, B. N.; Benacerraf, B., and Briot, M.: Role of Cortisone, Desoxycorticosterone and Adrenalin in Protecting Adrenalectomized Animals Against Hemorrhagic, Traumatic, and Histaminic Shock , Brit. J. Pharm. 7:287-297, 1952 388. Potentiation by Adrenaline of Protective Effect of Cortisone on Histamine Toxicity in Adrenalectomized Mice , Proc. Soc. Exper. Biol. & Med. 79:37-39, 1952. 389. Appel, S. B.; Fulton, L. A., and Orr, K. D.: Observations on Essentially Normal Young Men Treated with ACTH and Cortisone: II. Effects on Tuberculin, Dick, and Shick Tests , U. S. Armed Forces M. J. 3:373-384, 1952. 390. Goldman, L.; Thompson, R. G., and Trice, E. R.: Cortisone Acetate in Skin Disease: Local Effect in the Skin from Topical Application and Local Injection , A. M. A. Arch. Dermat. & Syph. 65:177-186, 1952. 391. Goldman, L.; Preston, R. H.; Rockwell, E., and Baskett, J.: Inhibition of Tuberculin Reaction by Local Injection of Compound F , J. A. M. A. 150:30-31, 1952. 392. Leahy, R. H., and Morgan, H. R.: Inhibition by Cortisone of the Cytotoxic Activity of PPD on Tuberculin-Hypersensitive Cells in Tissue Culture , J. Exper. Med. 96:549, 1952. 393. Pyke, D. A., and Scadding, J. G.: Effects of Cortisone Upon Skin. Sensitivity to Tuberculin in Sarcoidosis , Brit. M. J. 2:1126-1128, 1952. 394. Grace, A. W.; Frank, L., and Wyse, R. J.: Effect of Cortisone Upon Hypersensitivity Due to Lymphogranuloma Venereum , A. M. A. Arch. Dermat & Syph. 65:348-350, 1952. 395. Pickering, G. W.: Allergy and A. C. T. H. , Brit. M. J. 1:1207-1210, 1952. 396. Kerr, W. R., and Robertson, M.: Effect of ACTH, Cortisone, Sphingomyelin, Sphingosine and Phanergan (Antihistamine) in Inhibiting the Skin Reaction in Cattle Sensitized to Trichomonas Foetus Antigen , J. Hyg. 50:354, 1952. 397. Raben, M. S.; Rosenberg, I. N.; Westermeyer, V. W., and Astwood, E. B.: Enhanced Clinical Effectiveness of Purified Corticotropin , J. A. M. A. 148:844-845, 1952. 398. Renold, A. E.; Jenkins, D.; Forsham, P. H., and Thorn, G. W.: Intravenous ACTH: A Study in Quantitative Adrenocortical Stimulation , J. Clin. Endocrinol. 12:763, 1952. 399. Bruce, H. M., and Parkes, A. S.: A Slow-Release Medium for Adrenocorticotropic Hormone , Lancet 1:71-72, 1952. 400. Lamar, C. P.: Experiences with the Therapeutic Use of a Long-Acting Corticotrophic Preparation , J. Florida M. A. 39:167-173, 1952. 401. Wolfson, W. Q., and Fajans, S. S.: A Comparison of the Duration of Action of Various Long-Acting ACTH Preparations in Human Subjects , New England J. Med. 246:1000-1004, 1952.Crossref 402. Boland, E. W.: Antirheumatic Effects of Hydrocortisone (Free Alcohol), Hydrocortisone Acetate, and Cortisone (Free Alcohol) as Compared with Cortisone Acetate , Brit. M. J. 1:559-564, 1952.Crossref 403. Boland, E. W.: Rheumatoid Arthritis—Experiences with Hydrocortisone (Free Alcohol) and Hydrocortisone Acetate , California Med. 77:1-6, 1952. 404. Bilka, P. J.: Intra-Articular Use of Hydrocortisone in Rheumatic Diseases , Minnesota Med. 35:938-943, 1952. 405. Goldman, L.: Local Effect of Compound F on Reactions to Mosquito Bites , J. A. M. A. 149:265, 1952.Crossref 406. Sulzberger, M. B., and Witten, V. H.: Effect of Topically Applied Compound F in Selected Dermatoses , J. Invest. Dermat. 19:101-102, 1952.Crossref 407. Ziff, M.; Scull, E.; Ford, D.; McEwen, C., and Bunim, J. J.: Effects in Rheumatoid Arthritis of Hydrocortisone and Cortisone Injected Intra-Articularly , A. M. A. Arch. Int. Med. 90:774-784, 1952.Crossref 408. Steffensen, E. H.; Ivy, H. B., and Nagle, F. O.: Topical Compound F in the Treatment of Anterior Segment Eye Disease , Am. J. Ophth. 35:933-934, 1952. 409. Steffensen, E. H.: Corticotropin, Cortisone and Hydrocortisone in Treatment of Ocular Disease , J. A. M. A. 150:1660-1664 1952.Crossref 410. Abel, H.: Topical Cortisone in Eye Disease , Acta ophth. 30:45-52, 1952. 411. Bissell, G. W.: New Concepts in the Use of ACTH in Ophthalmology and Otolaryngology , Tr. Am. Acad. Ophth. 56:450-456, 1952. 412. Fine, M., and Goodwin, R. C.: Evaluation of Local Cortisone Therapy in Ophthalmology , A. M. A. Arch. Ophth. 47:787-797, 1952.Crossref 413. Franceschetti, A.; Maeder, G., and Bourquin, J. B.: La cortisone en ophtalmologie (observations expérimentales et cliniques) , Ann. ocul. 185:36-65, 1952. 414. François, J.: La cortisone en ophtalmologie , Ann. ocul. 185:401-413, 1952. 415. Irvine, S. R.: ACTH and Cortisone in Ophthalmology , Ann. West. Med. & Surg. 6:438-440, 1952. 416. Minnes, J. F.: Topical Cortisone in Eye Diseases , Canad, M. A. J. 66:342-347, 1952. 417. Ormsby, H. L.; Shirley, S. Y.; Aikenhead, J. F., and Murray, R. G.: ACTH and Cortisone Therapy in Eye Disease , Canad, M. A. J. 66:62-66, 1952. 418. Rouher, F.: Comment et quand utiliser la cortisone en ophtalmologie , Presse méd. 60:784-786, 1952. 419. Salomaa, S., and Swanljung, H.: Clinical Experiences with ACTH and Cortisone in Eye Diseases , Acta ophth. 30:53-61, 1952. 420. Thorpe, H. E.: Use of Cortisone and ACTH in Eye Diseases , Pennsylvania M. J. 55:236-240, 1952. 421. Woods, A. C.: Uses and Limitations of ACTH and Cortisone in Ophthalmology , Brit. J. Ophth. 36:401-431, 1952.Crossref 422. LaMotte, W. O., Jr.; Tyner, G. S., and Scheie, H. G.: Treatment of Retrolental Fibroplasia with Vitamin E, Corticotropin (ACTH) and Cortisone , A. M. A. Arch. Ophth. 47:556-569, 1952.Crossref 423. Reese, A. B.; Blodi, F. C.; Locke, J. C.; Silverman, W. A., and Day, R. L.: Results of Use of Corticotropin (ACTH) in Treatment of Retrolental Fibroplasia , A. M. A. Arch. Ophth. 47:551-555, 1952.Crossref 424. Cadman, E. F. B., and Robertson, A. J.: Treatment of Sjögren's Syndrome with A. C. T. H. , Brit. M. J. 2:68-70, 1952.Crossref 425. Sjögren, H., and Eriksen, A.: ACTH and Keratoconjunctivitis Sicca , Acta ophth. 30:463-465, 1952.Crossref 426. Ashton, N., and Hobbs, H. E.: Effect of Cortisone on Rheumatoid Nodules of the Sclera (Scleromalacia Perforans) , Brit. J. Ophth. 36:373-384, 1952.Crossref 427. Lepri, G.: Studies on Cortisone in Ophthalmology: I. Influence of Cortisone on the in-Vitro Effect of Antibiotics on Microorganisms Capable of Causing Ocular Infections: II. Action of Cortisone on Experimental Pneumococcic Infection of the Cornea and Its Influence on the Activity of Several Antibiotics , Am. J. Ophth. 35:935-946, 1952. 428. Carstensen, B., and Norviit, L.: ACTH und Cortison bei Sarcoidosis , Acta Soc. med. upsalien. 56:197-208, 1952. 429. Laval, J.: Ocular Sarcoidosis , Am. J. Ophth. 35:551-554, 1952. 430. Longcope, W. T., and Freiman, D. G.: A Study of Sarcoidosis , Medicine 31:1-132, 1952.Crossref 431. Ozazewski, J. C., and Bennett, V.: Ocular Sarcoidosis: Report of 3 Cases , Am. J. Ophth. 35:547-550, 1952. 432. Shulman, L. E.; Schoenrich, E. H., and Harvey, A. M.: Effects of Adrenocorticotropic Hormone (ACTH) and Cortisone on Sarcoidosis , Bull. Johns Hopkins Hosp. 91:371-415, 1952. 433. Drews, L. C.; Barton, G. D., and Mikkelson, W. M.: Syphilitic Interstitial Keratitis Am. J. Ophth. 36:90-103, 1953. 434. Oksala, A.: Interstitial Keratitis and Chorioretinitis , Acta ophth. 30:437-441, 1952.Crossref 435. Benedict, W., and Hollenhorst, R. W.: Cortisone and Blood Absorption , Am. J. Ophth. 36:247, 1953. 436. Mecklin, B., and Saunders, W.: Successful Treatment of Erythema Multiforme Exudativum (Stevens-Johnson Disease) with Cortisone , New York J. Med. 52:1447, 1952. 437. Robbins, M. H.: Bell's Palsy Successfully Treated with Cortisone , A. M. A. Arch. Ophth. 48:696-697, 1952.Crossref 438. Sullivan, C. P.: Sympathetic Ophthalmia Treated with Cortisone , Am. J. Ophth. 35:864-865, 1952. 439. Tillett, C. W.: Effect of ACTH on Normal Ocular Tension , Am. J. Ophth. 35:659-662, 1952. 440. Willis, W. D., Bargar, H. M.: Erythema Multiforme Exudativum: Report of a Case Treated with Cortisone , M. Bull. European Command 9:160-163, 1952. 441. Wyman, G. J.: Clearing of Corneal Infiltrates with Topical Cortisone , Am. J. Ophth. 35:1206-1207, 1952. 442. Kelley, V. C.: Corticotropin (ACTH) Therapy of Initial Attacks of Acute Rheumatic Fever in Children , A. M. A. Am. J. Dis. Child. 84:151-164, 1952. 443. Scheinkopf, J. A.; Criffith, G. C.; Morrison, R., and Starr, P.: Treatment of Rheumatic Fever with ACTH: I. Smaller Doses of ACTH in Acute Rheumatic Fever , Am. J. M. Sc. 224:390-397, 1952.Crossref 444. Shopfner, C. E., and Seife, M.: Treatment of Acute Rheumatic Fever with ACTH , U. S. Armed Forces M. J. 3:1153-1173, 1952. 445. Young D., and Rodstein, M. A.: Results of Cortisone-Corticotropin Therapy in Chronic Active Rheumatic Fever , A. M. A. Arch. Int. Med. 90:64-78, 1952.Crossref 446. Bunim, J. J.; Kuttner, A. G.; Baldwin, J. S., and McEwen, C.: Cortisone and Corticotropin in Rheumatic Fever and Juvenile Rheumatoid Arthritis , J. A. M. A. 150:1273-1278, 1952.Crossref 447. Jack, T.: A Case of Advanced Rheumatoid Arthritis Treated with Oral and Parenteral Cortisone , Glasgow M. J. 33:55-57, 1952. 448. Kersley, G. D.; Mandel, L., and Desmarais, M. H. L.: Absence of Response to Cortisone , Brit. M. J. 2:540-541, 1952.Crossref 449. Levin, M. H.; Rivo, J. B.; Scott, W.; Figueroa, W. G.; Fred, L., and Barrett, T. F.: Prolonged Treatment of Rheumatoid Arthritis with Cortisone and Corticotropin , Am. J. Med. 14:265-274, 1953.Crossref 450. Norcross, B. M.; Lockie, L. M.; Constantine, A. G.; Talbott, J. H., and Stein, R. H.: Effect of Cortone and ACTH on the Histopathologic Lesions of Rheumatoid Arthritis , Ann. Int. Med. 36:751-764, 1952.Crossref 451. Observations on the Effect of ACTH and Cortisone on Patients with Rheumatoid Arthritis, Staff of Queen Elizabeth Hospital , New Zealand M. J. 51:210-218, 1952. 452. Berry, C. Z.: The Use of ACTH in Dermatoses , U. S. Armed Forces M. J. 3:541-548, 1952. 453. Ficher, F., and Gillmor, S.: Periarteritis Nodosa , J. Missouri M. A. 49:320, 1952. 454. Frank, L., and Levitt, L. M.: Scleroderma with Raynaud's Syndrome Treated with Cortisone , New York J. Med. 52:353-354, 1952. 455. Lestina, F. A., and Markson, D. E.: Treatment of Systemic Lupus Erythematosus with ACTH , Quart. Bull. Northwestern Univ. M. School 26:133-137, 1952. 456. Reymann, F.; Sobye, P.; Schwartz, M., and Brodthagen, H.: ACTH Treatment in Pemphigus , Acta dermat.-venereol. 32:136-148, 1952. 457. Schneierson, S. J.: Orally Administered Cortisone in Erythema Nodosum , J. A. M. A. 150:585, 1952.Crossref 458. Sonne, L. M., and Schwartz, M.: Lupus Erythematosus Disseminatus: Four Cases Treated with ACTH , Acta dermat-venereol. 32:333-351, 1952. 459. Baldwin, H. S., and de Gara, P. F.: Hospital and Ambulatory Treatment of Asthma and Eczema with ACTH and Cortisone , J. Allergy 23:15-26, 1952.Crossref 460. Eklblad, G. H.: Use of Corticotropin (ACTH) and Cortisone in Urticaria and Dermatitis Venenata , U. S. Armed Forces M. J. 3:839-846, 1952. 461. Falk, M. S.; Allende, M. F., and Bennett, J. H.: Treatment of Severe Rhus Dermatitis with Corticotropin or Cortisone , J. Invest. Dermat. 18:307-310, 1952.Crossref 462. Hopkins, J. G.; Kesten, B. M.; Nelson, C. T.; Hambrick, G. W.; Jennings, R. G., Jr., and Machacek, G. F.: Pituitary Adrenocorticotropic Hormone (ACTH) and Cortisone in Diseases of the Skin: I. Allergic and Other Dermatoses; Report of 67 Cases , A. M. A. Arch. Dermat. & Syph. 65:401-421, 1952. 463. Podolsky, W. G.: Cortisone Treatment in Atopic Dermatitis , New York J. Med. 52:1180, 1952. 464. Steiner, K., and Frank, L.: Clinical Experiences with Cortisone and Corticotropin (ACTH) in Some Cutaneous Diseases , A. M. A. Arch. Dermat. & Syph. 65:524-534, 1952. 465. Sternberg, T. H.; Newcomer, V. D., and Linden, I. H.: Treatment of Atopic Dermatitis with Cortisone , J. A. M. A. 148:904-907, 1952. 466. West, B. M.: Three Patients with Exfoliative Dermatitis Treated with Cortisone: No Toxic Effects and Recovery was Dramatic , A. M. A. Arch. Dermat. & Syph. 65:56-58, 1952. 467. Aitchison, J. D.: Haemolytic Anemia Treated by ACTH, Cortisone and Splenectomy , Brit. M. J. 1:78-79, 1953. 468. Barondess, J. A.: Thrombotic Thrombocytopenic Purpura: Review of the Literature and Report of 3 Cases , Am. J. Med. 13:294-310, 1952. 469. Burchenal, J. H.: Present Status of ACTH, Cortisone, and the Antimetabolites in the Treatment of Leukemia and Related Diseases , Acta haemat. 7:193-205, 1952. 470. Davidson, L. S. P.; Girdwood, R. H., and Swan, H. T.: Effect of ACTH and Cortisone Therapy in Blood Disorders , Brit. M. J. 2:1059-1063, 1952. 471. Davis, L. J.; Kennedy, A. C.; Baikie, A. G., and Brown, A.: Haemolytic Anaemias of Various Types Treated with ACTH and Cortisone , Glasgow M. J. 33:263-285, 1952. 472. Englert, E., Jr., and Warshaw, L. J.: Familial Mediterranean (Cooley's) Anemia Complicated by Chronic Hepatitis: Results of Treatment with ACTH , Am. J. Med. 13:507- 516, 1952. 473. Hart, F. D.; Wraith, D. G., and Mansell, E. J. B.: Agranulocytosis Successfully Treated with ACTH , Brit. M. J. 1:1273-1275, 1952. 474. Heilmeyer, L.: ACTH- und Cortisontherapie bei nichtleukämischen Bluterkrankungen , Acta haemat. 7:206-216, 1952. 475. Stickney, J. M., and Mills, S. D.: Corticotropin and Cortisone in Blood Diseases in Children , J. A. M. A. 150:1278-1280, 1952. 476. Christensen, N. A.; Keith, H. M.; Smith, L. A.; Hanson, N. O., and Ralston, D. E.: Cortisone in the Treatment of Tetanus , Proc. Staff Meet., Mayo Clinic 27:28-32, 1952. 477. Reveno, W. S.; Rosenbaum, H., and Buell, J. H.: Short-Term Use of Corticotropin as Adjunctive Therapy , J. A. M. A. 149:1308-1309, 1952. 478. Workman, J. B.; Hightower, J. A.; Borges, F. J.; Furman, J. E.; and Parker, R. T.: Cortisone as an Adjunct to Chloramphenicol in the Treatment of Rocky Mountain Spotted Fever , New England J. Med. 246:962-966, 1952. 479. Traut, E. F., and Ellman, J.: Exacerbation of Tuberculosis During Treatment with Cortisone , J. A. M. A. 149:1214, 1952. 480. Walker, B.: Miliary Tuberculosis in a Case of Acute Disseminated Lupus Erythematosus Treated with ACTH , Brit. M. J. 2:1076-1078, 1952. 481. Bulova, P. N.; Becker, F. P., and Maslon, M.: Gastroduodenal Ulcer Following Cortisone Therapy: Report of a Case with Fatal Hemorrhage , New York J. Med. 52:1181-1182, 1952. 482. Davis, T. A., and Zeller, M.: Multiple Peptic Ulcers with Massive Hemorrhage During Oral Cortisone Therapy: Report of a Case , J. A. M. A. 150:31, 1952.Crossref 483. Tulin, M.; Kern, F., Jr., and Almy, T. P.: Perforation of Bowel During Treatment of Ulcerative Colitis with Corticotropin , J. A. M. A. 150:559-562, 1952.Crossref 484. Teicher, R., and Nelson, C. T.: Osteoporosis and Pathological Fractures Following Treatment with ACTH and Cortisone , J. Invest. Dermat. 19:205-210, 1952.Crossref 485. Traut, E. F.: Thyroiditis During Treatment with Cortisone , J. A. M. A. 149:832-833, 1952.Crossref 486. Fingl, E.; Olsen, L. J.; Harding, B. W.; Cockett, A. T., and Goodman, L. S.: Effect of Chronic Anticonvulsant Administration upon Cortisone-Induced Brain Hyperexcitability , J. Pharmacol. & Exper. Therap. 105:37-45, 1952. 487. Woodbury, D. M.: Effect of Adrenocortical Steroids and Adrenocorticotropic Hormone on Electroshock Seizure Threshold , J. Pharmacol. & Exper. Therap. 105:27-36, 1952. 488. Bennett, K.: Two New Concepts of the Mode of Action of Salicylates in Rheumatoid States , J. Bowman Gray School Med. 10:47-53, 1952. 489. Cronheim, G.; King, J. S., and Hyder, N.: Effect of Salicylic Acid and Similar Compounds on the Adrenal-Pituitary System , Proc. Soc. Exper. Biol. & Med. 80:51-55, 1952. 490. Pelloja, M.: Role of the Pituitary and Adrenal Glands in the Inhibition of Hyaluronidase by Salicylates in Vivo , Lancet 1:233-236, 1952. 491. van Cauwenberge, H., and Heusghem, C.: Thérapeutique par acide acétylsalicylique et excrétion urinaire des corticostéroides , Acta med. scandinav. 141:265-283, 1952. 492. Bach, F.; Freedman, A., and Bernstock, L.: Rheumatic Fever: Some Observations on A. C. T. H., Cortisone, and Salicylate Therapy , Brit. M. J. 2:582-587, 1952. 493. Hailman, H. F.: ACTH and Cortisone Versus Salicylates , J. Clin. Endocrinol. 12:454-457, 1952. 494. Smith, M. J. H.: Antagonistic Effects of Cortisone and Salicylate , Nature, London 170:240-241, 1952. 495. Ungar, G.; Damgaard, E., and Hummel, F. P.: Mechanism of Anti-Inflammatory Action of Sodium Salicylate , Federation Proc. 11:165, 1952. 496. Kuzell, W. C., and Schaffarzick, R. W.: Phenylbutazone (Butazolidin) and Butapyrin—A Study of Clinical Effects in Arthritis and Gout , California Med. 77:319-325, 1952. 497. Plichet, A.: Le traitement de arthrites rheumatismales et de la goutte par la phenylbutazone , Presse méd. 60:1217-1219, 1952. 498. Smith, C. H., and Kunz, H. G.: Butazolidin in Rheumatoid Disorders , J. M. Soc. New Jersey 49:306-309, 1952. 499. Steinbrocker, O.; Berkowitz, S.; Ehrlich, M.; Elkind, M., and Carp, S.: Phenylbutazone Therapy of Arthritis and Other Painful Musculoskeletal Disorders , J. A. M. A. 150:1087-1091, 1952. 500. Davies, H. R.; Barter, R. W.; Gee, A., and Hirson, C.: Observations on Use of "Butazolidin" in Arthritis , Brit. M. J. 2:1392-1394, 1952. 501. Patterson, R. M.; Benson, J. F., and Schoenberg, P. L.: Clinical Evaluation of Phenylbutazone , U. S. Armed Forces M. J. 4:109-111, 1953. 502. Hinz, C.; Lamont-Havers, R. W.; Cominsky, B., and Gaines, L. M.: Agranulocytosis Following Use of Phenybutazone (Butazolidin) , J. A. M. A. 151:38-39, 1953.Crossref 503. Stephens, C. A. L., Jr.; Yeoman, E. E.; Holbrook, W. P.; Hill, D. F., and Goodin, W. L.: Benefits and Toxicity of Phenylbutazone (Butazolidin) in Rheumatoid Arthritis , J. A. M. A. 150:1084-1086, 1952.Crossref 504. Wilkinson, E. L., and Brown, H.: Effect of Butazolidin (Phenylbutazone) on Water and Electrolyte Excretion , Am. J. M. Sc. 225:153-158, 1953.Crossref 505. Green, T. W.; White, W. E.; Engelman, E. P., and Krupp, M. H.: Effect of Butazolidin-r on 1-131 Uptake by the Thyroid Gland , Proc. Soc. Exper. Biol. & Med. 82:155-157, 1953. 506. Scott, K. G.; Frerichs, J. B., and Reilly, W. A.: Effect of Butazolidin upon the Fate of 1-131 in the Rat , Proc. Soc. Exper. Biol. & Med. 82:150-152, 1953. 507. Dawson, M., and Todd, J. P.: Assay of Bacterial Pyrogens , J. Pharm. & Pharmacol. 4:972-979, 1952. 508. Seibert, F. B.: Symposium on Bacterial Pyrogens: Introduction , Tr. New York Acad. Sc. 14:157-159, 1952. 509. Windle, W. F.: Activities of Certain Bacterial Polysaccharides , Tr. New York Acad. Sc. 14:159-161, 1952. 510. Zahl, P., and Hutner, S. H.: Biology of Pyrogens , Tr. New York Acad. Sc. 14:161-163, 1952. 511. Bailey, A. A.; Rooke, E. D., and Rodin, E. A.: Investigations of a Bacterial Pyrogen as a Therapeutic Agent in Neurologic Disorders , Proc. Staff Meet., Mayo Clin. 27:340-343, 1952. 512. Newell, F. W.: Fever Therapy in Ophthalmology Today , Quart. Bull. Northwestern Univ. M. School 26:151-156, 1952. 513. Rosen, D. A.: Effect of Intravenous Typhoid Vaccine on Adrenal Cortex Function , Am. J. Ophth. 35:1783-1790, 1952. 514. Schofield, B. M.: Action of Nicotine on the Ciliary Ganglion , Brit. J. Pharmacol. 7:665-669, 1952. 515. tum Suden, C.; Hart, E. R., and Marrazzi, A. S.: Influence of Acetylcholine on Synaptic Transmission in a Parasympathetic Ganglion (Ciliary) , Federation Proc. 11:164, 1952. 516. Koelle, G. B.; Friedenwald, J. S.; Allen, R. A., and Wolfand, L.: Localization of Specific Cholinesterase in Ocular Tissues of the Cat , Am. J. Ophth. 35:1580-1584, 1952. 517. Schofield, B. M.: Cholinesterase in the Iris After Removal of the Ciliary Ganglion , Brit. J. Pharmacol. 7:670-673, 1952. 518. Goldstein, A., and Hamlisch, R. E.: Properties and Behavior of Purified Human Plasma Cholinesterase: IV. Enzymatic Destruction of the Inhibitors Prostigmine and Physostigmine , Arch. Biochem. 35:12-22, 1952. 519. Jansen, E. F.: Jang, R., and Balls, A. K.: Inhibition of Purified Human Plasma Cholinesterase with Di-Isopropyl Fluoro-Phosphate , J. Biol. Chem. 196:247-253, 1952. 520. Frawley, J. P.; Hagen, E. C., and Fitzhugh, O. G.: A Comparative Pharmacological and Toxicological Study of Organic Phosphate-Anticholinesterase Compounds , J. Pharmacol. & Exper. Therap. 105:156-165, 1952. 521. Chamberlin, H. R.; Hill, C., and Cooke, R. E.: Organic Phosphate Insecticide Poisoning , A. M. A. Am. J. Dis. Child 85:164-172, 1953. 522. DuBoise, K. P., and Coon, J. M.: Toxicology of Organic Phosphorus-Containing Insecticides to Mammals , A. M. A. Arch. Indust. Hyg 6:9-13, 1952. 523. Grob, D., and Harvey, A. M.: Effects and Treatment of Nerve Gas Poisoning , Am. J. Med. 14:52-63, 1953.Crossref 524. Kay, K.; Monkman, L.; Windish, J. P.; Doherty, T.; Pare, J., and Racicot, C.: Parathion Exposure and Cholinesterase Response of Quebec Apple Growers , A. M. A. Arch. Indust. Hyg. 6:252-262, 1952. 525. Lieben, J.: Medical Importance of Organic Phosphorus Insecticides , Connecticut M. J. 16:407-408, 1952. 526. Linn, J. G., Jr., and Tomarelli, R. C.: An Evaluation of the Various Anticholinesterase Agents , Am. J. Ophth. 35:46-53, 1952. 527. Leopold, I. H., and Cleveland, A. F.: DFP in Glaucoma , Am. J. Ophth. 36:226, 1953. 528. de Ocampo, G.: Di-Isopropyl Fluorophosphate (DFP) in Cycloplegic Refraction , Am. J. Ophth. 35:1484-1489, 1952. 529. Butler, W. E.: Acute Glaucoma Precipitated by DFP: Report of a Case , Am. J. Ophth. 35:1031-1033, 1952. 530. La Rocca, V.: Retinal Detachment from Di-Isopropyl Fluorophosphate in an Aphakic Eye , New York J. Med. 52:1329-1330, 1952. 531. Walsh, F. B.: Myasthenia Gravis—Diagnosis and Treatment , Rocky Mountain M. J. 49:757-766, 1952. 532. Wilson, A.: Myasthenia Gravis , Glasgow M. J. 33:381, 1952. 533. Schwarz, H.: Curare-like Factor in Serum of Myasthenia Gravis Patients , Canad. M. A. J. 67:238-247, 1952. 534. Osserman, K. E., and Kaplan, L. I.: Rapid Diagnostic Test for Myasthenia Gravis Employing Edrophonium (Tensilon) Chloride , J. A. M. A. 150:265-268, 1952.Crossref 535. Chodoff, P., and McGreevy, J. R.: Myasthenia Gravis—A Survey , M. Ann. District of Columbia 21:307-311, 1952. 536. Schlezinger, N. S.: Present Status of Therapy in Myasthenia Gravis , J. A. M. A. 148:508-513, 1952.Crossref 537. Gregory, L., Jr.; Futch, E. D., and Stone, C. T.: Octamethyl Pyrophosphoramide in the Therapy of Myasthenia Gravis , Am. J. Med. 13:423-428, 1952.Crossref 538. Wilson, C. W.; Williams, J. P., and Miller, D. H.: The Hazard of Cholinergic Crisis During Treatment of Myasthenia Gravis with Octamethyl Pyrophosphoramide , Ann. Int. Med. 37:574-579, 1952.Crossref 539. (a) Gettes, B. C., and Leopold, I. H.: Evaluation of 5 New Cycloplegic Drugs , A. M. A. Arch. Ophth. 49:24-27, 1953.Crossref 540. (b) Stolzer, I. H.: A New Group of Cycloplegic Drugs , Am. J. Ophth. 36:110-112, 1953. 541. Raiford, M. B.: Use of Banthine in Ophthalmology , South. M. J. 45:633-636, 1952.Crossref 542. Reiter, C.: A New Synergistic Mydriatic Combination , Am. J. Ophth. 35:412-413, 1952. 543. Liebowitz, D.; Raisin, A.; Berry, C., and Roth, H. P.: Treatment of Intractable Peptic Ulcer with Methantheline (Banthine) Bromide , J. A. M. A. 150:672-677, 1952.Crossref 544. Steinberg, N.: New Anticholinergic Drugs in Peptic Ulcer Therapy , Rev. Gastroenterol. 19:351-370, 1952. 545. Hufford, A. R.: Bentyl Hydrochloride: Successful Administration of a Parasympatholytic Anti-Spasmodic in Glaucoma Patients , Am. J. Digest. Dis. 19:257-258, 1952.Crossref 546. Marks, J. A.: Prantal Methylsulfate—A New Anticholinergic Drug for the Treatment of Peptic Ulcer , New York J. Med. 52:1783-1789, 1952. 547. Texter, E. C., Jr.; Baylin, G. J.; Legerton, C. W., Jr., and Ruffin, J. M.: Effects of a New Cholinergic Blocking Agent (SKF-1637) on Gastric Motor and Secretory Activity , Am. J. M. Sc. 224:612-618, 1952.Crossref 548. Vogel, W. F., and Paterson, N. J.: Clinical Results with Prantal Methylsulfate , J. M. Soc. New Jersey 49:105-110, 1952. 549. Biel, J. H.; Friedman, H. L.; Leiser, H. A., and Sprengeler, E. P.: Antispasmodics: Substituted Acetic Acid Esters of 1-Alkyl-3-Hydroxypiperidine , J. Am. Chem. Soc. 74:1485-1488, 1952.Crossref 550. Cheney, L. C.; Wheatley, W. B.; Speeter, M. E.; Byrd, W. M.; Fitzgibbon, W. E.; Minor, W. F., and Binkley, S. B.: Basic Amides as Antispasmodic Agents: I. , J. Organic Chem. 17:770-777, 1952.Crossref 551. Moffett, R. B., and Hunter, J. H.: Antispasmodics: Mono- and Dimethyltyrrolidylalkyl Esters of Disubstituted Acetic Acids , J. Am. Chem. Soc. 74:1710-1712, 1952.Crossref 552. Ruddy, A. W., and Bishop, H. W.: Antispasmodics: N-Methyl-2(4)-(W-R-W-Phenylalkyl)-Piperidines and 2-R-2-Phenyl-4(5)-(N-Methyl-4-Piperidyl)-Alkanenitriles , J. Am. Chem. Soc. 74:1919-1921, 1952.Crossref 553. Litman, R. E.: Heat Sensitivity to Autonomic Drugs , J. A. M. A. 149:635-636, 1952.Crossref 554. Outschoorn, A. S.: The Nature of Sympathin Released in the Rabbit's Ear , Brit. J. Pharmacol. 7:616-624, 1952. 555. Swan, H. J. C.: Noradrenaline, Adrenaline and the Human Circulation , Brit. M. J. 1:1003-1006, 1952.Crossref 556. Shepherd, D. M., and West, G. B.: Noradrenaline and Accessory Chromaffin Tissue , Nature, London 170:42-43, 1952.Crossref 557. Robinson, J.: Amine Oxidase in the Iris and Nictitating Membrane of the Cat and the Rabbit , Brit. J. Pharmacol. 7:99-102, 1952. 558. Burn, J. H.: The Enzyme at Sympathetic Nerve Endings , Brit. M. J. 1:784-787, 1952.Crossref 559. Angenent, W. J., and Koelle, G. B.: Destruction of Epinephrine by the DOPA-Oxidase System of Ocular Tissue , Science 116:543-544, 1952.Crossref 560. Bedrossian, R. H., and Deichler, J. W.: Phenylephrine (Neo-Synephrine) Ointment , A. M. A. Arch. Ophth. 48:747-748, 1952.Crossref 561. Lipsius, E. I.: Paredrine Hydrobromide in Chronic Conjunctivitis , Am. J. Ophth. 35:1692-1695, 1952. 562. Livesay, W. R., and Chapman, D. W.: Treatment of Acute Hypotensive States with 1-Norepinephrine , Am. J. M. Sc. 225:159-171, 1953.Crossref 563. Lands, A. M., and Tainter, M. L.: Sympathomimetic Amines in the Treatment of Peripheral Circulatory Failure , M. Ann. District of Columbia 21:63-69, 1952. 564. Mayer, R. A., and Ruben, J. E.: Arterenol (Nor-Epinephrine): II. In Clinical Anesthesiology , J. Philadelphia Gen. Hosp. 3:18-21, 1952. 565. von Euler, U. S.: Some Aspects of the Clinical Physiology of Noradrenaline , J. Clin. & Lab. Invest. 4:254-262, 1952. 566. Greenwald, H. P.; Gootnick, A.; Luger, N. M., and King, J. A.: Tissue Necrosis Following Subcutaneous Infiltration with Nor-Epinephrine , New England J. Med. 246:252-253, 1952. 567. Muehrcke, R. C.; Staple, T. W., and Kark, R. M.: Epinephrine Eosinopenia in Surgically Induced Addison's Disease , J. Lab. & Clin. Med. 40:169-173, 1952. 568. Dick, H. L.: Use of Amphetamine in Barbiturate Poisoning , Am. J. M. Sc. 224:281-285, 1952. 569. Brofman, B. L.: Hellerstein, H. K., and Caskey, W. M.: Mephentermine—An Effective Pressor Amine , Am. Heart J. 44:396-406, 1952. 570. Nathanson, M. H., and Miller, H.: Clinical Observations on a New Epinephrine-like Compound, Methoxamine , Am. J. M. Sc. 223:270-279, 1952. 571. Sutton, B. M., and Data, J. B.: Vasoconstrictors: 2-Amino Derivatives of Certain Alkoxyalkanes , J. Am. Pharm. A. (Scient. Ed.) 41:328-332, 1952. 572. Taylor, G. W.: Clinical Evaluation of Armine, a New Sympathomimetic Amine , A. M. A. Arch. Otolaryng. 56:213-214, 1952. 573. Taeschler, M.; Cerletti, A., and Rothlin, E.: Zur Frage der Hyderginwirkung auf die Gehirnzirkulation , Helvet. physiol. et pharmacol. acta 10:120-137, 1952. 574. Fuchs, M., and Blumenthal, L. S.: Use of Ergot Drugs for Migraine , M. Ann. District of Columbia 21:372-375, 1952. 575. Polonovski, M.; Schmitt, H., and Pelou, A.: Activité adrénolytique et sympatholytique d'un dérivé, la N-phenoxyisopropyl-N-benzyl-β-chloroéthylamine , Compt. rend. Soc. biol. 146: 1560-1563, 1952. 576. Harvey, S. C.; Wang, C. Y., and Nickerson, M.: Blockade of Epinephrine-Induced Hyperglycemia , J. Pharmacol. & Exper. Therap. 104:363-376, 1952. 577. Graham, J. D. P., and Lewis, G. P.: Relationship Between Anti-Adrenaline and Anti-Histamine Activity in a Series of β-Haloethylamines , J. Physiol. 116:37P-38P, 1952. 578. Brodie, B. B.; Aronow, L., and Axelrod, J.: Fate of Benzazoline (Priscoline) in Dog and Man and a Method for Its Estimation in Biological Material , J. Pharmacol. & Exper. Therap. 106:200-207, 1952. 579. Harris, J. E., and Gehrsitz, L. B.: Unpublished data. 580. Gibbs, D. F.: Dihydrogenated Alkaloids of Ergot in the Investigation and Treatment of Diastolic Hypertension , Brit. Heart J. 14:77-86, 1952. 581. Cholst, M. R.; Schilback, H. F.; Handelsman, M. B., and Levitt, L. M.: Response of the Retinal Vessels to Priscoline in Various Vascular Conditions: Study I. , Am. J. Ophth. 35:191-195, 1952. 582. Stern, J. J.: A New Vasodilator in Ophthalmology , Am. J. Ophth. 35:187-190, 1952. 583. Cholst, M. R.; Schilback, H. F.; Handelsman, M. B., and Levitt, L. M.: Response of the Retinal Vessels into Priscoline Diabetes Mellitus: Study II. , Am. J. Ophth. 35:375-380, 1952. 584. Haimovici, H.: Use of Dibenamine in Pheochromocytoma and Detection of Pressor Activity of the Plasma by Bio-Assay , J. Mt. Sinai Hosp. 19:320-327, 1952. 585. Hurley, L. A., and Buchanan, A. R.: Prophylactic and Therapeutic Value of Hydergine in High Altitude Frostbite , Surg., Gynec. & Obst. 95:423-430, 1952. 586. Mufson, I.; Goldman, L.; Hirschman, S.; Sheiman, M.; Blier, J., and Steinberg, G.: An Evaluation of Priscoline by Artery in the Treatment of Peripheral Arterial Obliterativve Disease , New York J. Med. 52:2651-2654, 1952. 587. Roberts, J. E.; Anderson, L. L., and Parry, T. M.: Clinical Effectiveness of Certain of the Hydrogenated Alkaloids of Ergot in Peripheral Vascular Disorders , Am. J. M. Sc. 224:431-438, 1952. 588. Bakke, J. L., and Williams, R. H.: Treatment of Essential Hypertension with β-Alkylamines, Especially Dibenzyline , Am. J. Med. 14:141-159, 1953. 589. Elek, S. R.; MeNair, J. D., and Griffith, G. C.: Clinical Comparison of 2 Hypotensive Drugs: Newer Ergot and Veratrum Alkaloids , Am. Pract. & Digest Treat. 3:693-696, 1952. 590. Ertwisle, G., and Stone, C. A.: Effect of Prolonged Administration of Adrenergic Blocking Drug on Blood Pressure of Hypertensive Dogs , Am. J. Physiol. 172:245-250, 1953. 591. Sutton, G. C.; Buckingham, W.; Brown, R. D., and Sutton, D. C.: A Clinical Evaluation of the Treatment of Hypertension with Dihydrogenated Ergotoxine Alkaloids , Am. Heart J. 44:622-628, 1952. 592. Atkinson, W. J., Jr.: Effect of Tetraethylammonium Chloride on Mammalian Skeletal Muscle Action , Am. J. Physiol. 168:442-445, 1952. 593. Paton, W. D. M., and Zaimis, E. J.: The Methonium Compounds , Pharmacol. Rev. 4:219-253, 1952. 594. Pocidalo, J. J.; Himbert, J., and Tardieu, C.: Sur l'excitabilité du sympathique: Influence de quelques drogues à ammonium quaternaire , Presse méd. 60:204-206, 1952. 595. Goldstone, B.: Death Associated with Methonium Treatment , South African M. J. 26:552-554, 1952. 596. Finnegan, T. R. L., and Trounce, J. R.: Intolerance to Hexamethonium Bromide , Brit. M. J. 2:75-76, 1952. 597. Goldsmith, A. J. B., and Hewer, A. J. H.: Unilateral Amaurosis with Partial Recovery After Using Hexamethonium Iodide , Brit. M. J. 2:759-760, 1952. 598. Barnett, A. J.: Ocular Effects of Methonium Compounds , Brit. J. Ophth. 33:593-602, 1952. 599. Cameron, A. J., and Burn, R. A.: Hexamethonium and Glaucoma , Brit. J. Ophth. 36:482-491, 1952. 600. Gillies, J.: Physiological Trespass in Anesthesia , Proc. Roy. Soc. Med. 45:1-6, 1952. 601. Kenney, S.: Controlled Hypotension , Irish J. M. Sc. 6:241-253, 1952. 602. Hill, K. R., and Goodwin, G. P.: Influence of Hypotension on the Intracapsular Cataract Operation , Brit. J. Ophth. 36:683-688, 1952.Crossref 603. Rycroft, B. W., and Romanes, G. J.: Preliminary Report on the Use of Methonium Compounds and General Anaesthesia in Ophthalmic Surgery , Brit. J. Ophth. 36:29-36, 1952.Crossref 604. Davies, G.; Wales, B. A.; Paterson, A. S., and Oxon, M. A.: Use of "Etamon" for High Blood-Pressure in Electrocerebral Treatment , J. Ment. Sc. 98:306-308, 1952. 605. Johnson, I; Moyer, J. H.; Mills, L. C., and Miller, S. I.: Treatment of Hypertension: Results with Hexamethonium Salts Administered Orally , Texas J. Med. 48:331-334, 1952. 606. McMichael, J.: Management of Hypertension , Brit. M. J. 1:933-938, 1952.Crossref 607. McQueen, E. G.: Treatment of Hypertension with Hexamethonium Bromide , M. J. Australia 2:425-428, 1952. 608. Palmer, A. J.: Management of Hypertension with Hexamethonium Bromide , M. J. Australia 2:428-435, 1952. 609. Robinson, C. M.: The Methonium Compounds and Their Use in the Treatment of Hypertension , J. Bowman Gray School Med. 10:87-95, 1952. 610. Shaw, G. B.: Continuous Oral Hexamethonium in Essential Hypertension: Further Experiences in Treatment , Glasgow M. J. 33:410-420, 1952. 611. Khan, M. A.: Effect of Hydralazine in Hypertension , Brit. M. J. 1:27-29, 1953.Crossref 612. Riven, S. S., and others: Control of Hypertension with 1-Hydrazinophthalazine (Apresoline) , Am. J. Med. 14:160, 1953.Crossref 613. Moyer, J.; Miller, S. I.; Tashnek, A. B.; Snyder, H., and Bowman, R. O.: Malignant Hypertension and Hypertensive Encephalopathy: Cerebral Hemodynamic Studies and Therapeutic Response to Continuous Infusion of Intravenous Veriloid , Am. J. Med. 14:175-183, 1953.Crossref 614. Shapiro, A. P.; Brust, A. A., and Ferris, E. B.: A Comparative Study of the Effects of Veratrum Viride and Tetraethylammonium Chloride in Hypertension , Ann. Int. Med. 36:807-810, 1952.Crossref 615. Stearns, N. S., and Ellis, L. B.: Acute Effects of Intravenous Administration of a Preparation of Veratrum Viride in Patients with Severe Forms of Hypertensive Disease , New England J. Med. 246:397-400, 1952.Crossref 616. Swiss, E. D., and Maison, G. L.: Site of Cardiovascular Action of Veratrum Derivatives , J. Pharmacol. & Exper. Therap. 105:87-95, 1952. 617. Grimson, K. S.; Orgain, E. S.; Rowe, C. R., and Sieber, H. A.: Caution with Regard to Use of Hexamethonium and "Apresoline," J. A. M. A. 149:215-220, 1952. 618. Johnson, R. L.; Freis, E. D., and Schnaper, H. W.: Clinical Evaluation of 1-Hydrazinophthalazine (C-5968) in Hypertension with Special Reference to Alternating Treatment with Hexamethonium , Circulation 5:833-841, 1952. 619. Schroeder, H. A.: Control of Hypertension by Hexamethonium and 1-Hydrazinophthalazine , A. M. A. Arch. Int. Med. 89:523-540, 1952. 620. Sommerville, J., and MacMillan, J. B.: Treatment of Essential Hyperidrosis with Hexamethonium Bromide: A Preliminary Report , Brit. J. Dermat. 64:442-446, 1952. 621. Hirshleifer, I.; Schwartz, G.; Fuerst, H. J., and Fankhauser, A.: Tetraethylammonium Chloride in the Treatment of Coronary Artery Disease , New York J. Med. 52:575-579, 1952. 622. Aaron, R. S., and Weston, R. E.: Outpatient Treatment of Congestive Heart Failure with Sodium-Removing Exchange Resins , A. M. A. Arch. Int. Med. 90:182-195, 1952.Crossref 623. Best, M. M.: Use of an Anion-Cation Exchange Resin in Edematous States Contraindicating Mercurial Diuretics , Am. Pract. & Digest Treat. 3:274-279, 1952. 624. Gill, R. J., and Duncan, G. G.: Clinical Use of Alginic Acid as a Cation Exchanger , Am. J. M. Sc. 224:569-572, 1952 625. Arterial Hypertension—the Therapeutic Effect of Cation-Exchange Resins , New England J. Med. 247:271-276, 1952. 626. Whiting, W. B., and Miller, M. S.: Cation Exchange Resins , Texas J. Med. 48:585-590, 1952. 627. Bonner, C. D.: Electrolyte-Balance Studies in Normal Volunteers and Clinical Observations on the Effects of Cation-Exchange Resins in Patients with Cardiovascular Disease and in Subjects Receiving Pituitary Adrenocorticotropic Hormone (ACTH) , New England J. Med. 247:158-163, 1952. 628. Greenman, L.; Weigland, F. A., and Danowski, T. S.: Cation Exchange Resin Therapy in Patients Receiving Cortisone or ACTH , Am. J. M. Sc. 225:1-7, 1953. 629. Agarwal, L. P., and Mathur, S. P.: Curare in Ocular Surgery: Report of 25 Cases , Brit. J. Ophth. 36:603-610, 1952. 630. Thomas, K. B.: D-Tubocurarine Chloride in Strabismus Operations in Children , Anæsthesia 7:97-98, 1952. 631. Naess, K.: The Mechanism of Action of Curare , Acta pharmacol. et toxicol. 8:149-163, 1952. 632. Sniper, W.: Estimation and Comparison of Histamine Release by Muscle Relaxants in Man , Brit. J. Anæsth. 24:232-237, 1952. 633. Doughty, A. G., and Wylie, W. D.: Antidotes to "True" Curarizing Agents, Including a Report on Ro 2-3198 (Tensilon) , Brit. J. Anæsth. 24:66-80, 1952. 634. Hunter, A. R.: Tensilon: A New Anti-Curare Agent , Brit. J. Anæsth. 24:175-186, 1952. 635. Smith, C. M.; Cohen, H. L.; Pelikan, E. W., and Unna, K. R.: Mode of Action of Antagonists to Curare , J. Pharmacol. & Exper. Therap. 105:391-399, 1952. 636. Fuller, J. D.: Advantages of the Preoperative Use of Slowly Absorbed D-Tubocurarine , Anesthesiology 13:370-375, 1952. 637. Adamson, D. C., and Kinsman, F. M.: Succinyl Choline Chloride in Anaesthesia , Anæsthesia 7:166-168, 1952. 638. Churchill-Davidson, H. C., and Richardson, A. T.: Decamethonium Iodide (C 10): Some Observations on Its Action Using Electromyography , Proc. Roy. Soc. Med. 45:179-186, 1952. 639. Hall, L. W.; Lehmann, H., and Silk, E.: Response in Dogs to Relaxants Derived from Succinic Acid and Choline , Brit. M. J. 1:134-136, 1953. 640. Mayrhofer, O. K.: Self-Experiments with Succinylcholine Chloride , Brit. M. J. 1:1332-1334, 1952. 641. Mesham, P. R., and Barton, J. D. M.: A Report on Succinylcholine Chloride (Scoline): An Ultra-Short-Acting Muscle Relaxant , South African M. J. 26:727-728, 1952. 642. Thesleff, S.: Pharmacological Properties of Succinylcholine Iodide: With Particular Reference to Its Clinical Use as a Muscular Relaxant , Acta physiol. scandinav. 26:103-129, 1952Crossref 643. An Investigation of the Muscle-Relaxing Action of Succinyl-Choline-Iodide in Man , Thesleff Acta physiol. scandinav. 25:348-367, 1952Crossref 644. An Investigation of Succinyl-Choline-Iodide in Man , Thesleff Acta physiol. scandinav. 25:368-376, 1952.Crossref 645. Phillips, A. P.: Dicarboxylic Acid bis-β-Tertiaryaminoalkyl Amides and Their Quaternary Ammonium Salts and Curare Substitutes: III. J. Am. Chem. Soc. 74:4320-4321, 1952.Crossref 646. Evans, F. T.; Gray, P. W. S.; Lehmann, H., and Silk, E.: Effect of Pseudo-Cholin-esterase Level on Action of Succinylcholine in Man , Brit. M. J. 1:136-138, 1953.Crossref 647. Whittaker, V. P., and Wijesundera, S.: Hydrolysis of Succinyldicholine by Cholinesterase , Biochem. J. 52:475-479, 1952. 648. von Dardel, O., and Thesleff, S.: Succinylcholine Iodide as a Muscular Relaxant: A Report of 500 Surgical Cases , Acta chir. scandinav. 103:321-336, 1952. 649. Thesleff, S., and Holmberg, G.: Succinylcholine Iodide: A New Muscular Relaxant , Brit. J. Anæsth. 24:238-244, 1952.Crossref 650. Vetten, K. B.; Nicholson, J. C., and Devitt, D. C.: Safety in the Use of Muscular Relaxants , South African M. J. 26:814-817, 1952. 651. Foldes, F. F.; Machaj, T. S.; Hunt, R. D.; McNall, P. G., and Carberry, P. C.: Synthetic Muscle Relaxants in Anesthesia , J. A. M. A. 150:1559-1566, 1952.Crossref 652. Berger, F. M.: Central Depressant and Anticonvulsant Properties of Glycerol Ethers Isomeric with Mephenesin , J. Pharmacol. & Exper. Therap. 105:450-457, 1952. 653. Davis, H.; Hine, C. H.; Neal, M. W.; Christensen, H. E., and Murphy, F. J.: Some Pharmacologic Comparisons of 1-Ethoxy- 3-Isopropoxypropane-2-ol and 3-(2-Methylphenoxy)-Propane-1,2-Diol (Myanesin) , Arch. internat. pharamcodyn. 89:145-159, 1952. 654. Taverner, D.: Action of α-β-Dihydroxy-γ-(2-Methylphenoxy)-Propane (Myanesin) on the Spinal Cord of the Cat , Brit. J. Pharmacol. 7:655-664, 1952. 655. Album, M. M.: Dental Use of Mephenesin in Cerebral Palsy Patients: A Preliminary Report , J. Am. Dent. A. 45:165-170, 1952. 656. Libet, B., and Rubin, D.: Mephenesin in the Treatment of Spasticity in Multiple Sclerosis , J. Nerv. & Ment. Dis. 116:198-209, 1952. 657. Loew, E. R.: Pharmacological Properties of Antihistaminics in Relation to Allergic and Nonallergic Disease , Boston M. Quart. 3:1-6, 1952. 658. Slater, I. H., and Dresel, P. E.: Pressor Effect of Histamine After Autonomic Ganglionic Blockade , J. Pharmacol. & Exper. Therap. 105:101-107, 1952. 659. Flanders, J. F.; Heckler, G. B., and Jones, R. E.: Intra-Arterial Histamine in Peripheral Vascular Disease , Delaware M. J. 24:17-21, 1952. 660. Furmanski, A. R.: Histamine Therapy in Acute Ischemia of the Brain , A. M. A. Arch. Neurol. & Psychiat. 69:104-117, 1953. 661. Prewitt, L. H.: Histamine in the Practice of Otolaryngology , Tr. Am. Acad. Ophth. 56:280-282, 1952. 662. Schmidt, A.: A Review of Histamine and Its Clinical Use , J. Missouri M. A. 49:235-243, 1952. 663. Skinner, D. A.: Histamine in Bell's Palsy , Tr. Am. Acad. Ophth. 56:283-286, 1952. 664. Mitchell, R. B.; Arnold, A. C., and Chinn, H. I.: Fungistatic Activity of Antihistamines , J. Am. Pharm. A. (Scient. Ed.) 41:472-475, 1952.Crossref 665. Fabinyi-Szebehely, M., and Szebehely, J.: Influence of Antihistamines on the Effect of Histamine upon Body Temperature and Oxygen Consumption in Mice and Rats , Acta physiol. scandinav. 27:1-9, 1952.Crossref 666. Kopel, D.: Comparison of the Anaesthetic Effects of Antihistamine and Local Anaesthetic Drugs of the Skin , Dermatologica 104:408-414, 1952.Crossref 667. Murray, J. R., and Houston, M. J.: Effect of Diphenhydramine Hydrochloride (Benadryl HC1) on Skeletal Muscle , Arch. internat. pharmcodyn. 89:204-208, 1952. 668. Barris, R. W.: Use of Benadryl for Symptomatic Relief of "Thalamic Pain," Neurology 2:59-64, 1952.Crossref 669. Guard, H. L.: Benadryl Intoxication: A Case Report , M. Bull. European Command 9:17-20, 1952. 670. Ellis, F. A., and Bundick, W. R.: Appraisal of Topical Use of Antihistamines , J. A. M. A. 150:773-776, 1952.Crossref 671. Hurwitz, P:. Prophenpyridamine Maleate (Trimeton Maleate) in Ocular Allergy , Eye, Ear, Nose & Throat Month. 31:251-254, 1952. 672. Hurwitz, P.: Drilitol in External Ocular Diseases , Am. J. Ophth. 35:1134-1138, 1952. 673. Tucker, W. I., and O'Neill, P. B.: Benadryl in Histamine Headache , Lahey Clin. Bull. 7:218-221, 1952. 674. Finkler, R. S.: Topical Antihistamine Therapy in Ano-Genital Pruritis , J. M. Soc. New Jersey 49:264-265, 1952. 675. Inman, P.; Cowan, I., and Campbell, C.: Antihistamine in Non-Urticarial Dermatoses and Retrial of Antihistamine Iontophoresis , Brit. M. J. 1:1064-1066, 1952. 676. Boyd, E. M.: Cough Medication and Antihistaminic Drugs , Canad. M. A. J. 67:289-292, 1952. 677. Chinn, H. I.; Handford, S. W.; Cone, T. E.; and Smith, P. K.: Effectiveness of Various Drugs for the Prophylaxis of Seasickness , Am. J. Med. 12:433-439, 1952. 678. Chinn, H. I., and Milch, L. J.: Comparison of Airsickness Preventives , J. Appl. Physiol. 5:162-164, 1952. 679. Moore, D. C.; Anderson, LeG.; Wheeler, G., and Scheidt, J.: Use of Parenteral Dramamine to Control Postoperative Vomiting: A Report of 1,192 Cases , Anesthesiology 13:354-360, 1952. 680. Cohen, S. G., and Criep, L. H.: Observations on the Use of Antihistaminics in Parkinson's Disease (Paralysis Agitans) , J. Nerv. & Ment. Dis. 115:57-63, 1952 681. Day, T. D.: Permeability of Interstitial Connective Tissue and the Nature of the Interfibrillary Substance , J. Physiol. 117:1-8, 1952. 682. Duran-Reynals, F., and Duran-Reynals, M. L.: Inactivation of Vaccine Virus by Preparations of Hyaluronic Acid With or Without Hyaluronidase: Experiments on Cell Cultures , Science 115:40-41, 1952.Crossref 683. Nordqvist, P.: Action of Hyaluronidase on Frog Sciatic Nerve, with Special Reference to Penetration of Procaine , Acta pharmacol. et toxicol. 8:195-206, 1952.Crossref 684. Pirozynski, W. J., and Webster, D. R.: Effect of Hyaluronidase on Edema Following Experimental Cold Injury , Proc. Soc. Exper. Biol. & Med. 80:306-308, 1952 685. Ludany, G.; Orban, T., and Vajda, G.: Hyaluronidase und die Bakterienphagozytose der Leukozyten , Arch. internat. pharmacodyn. 88:496-501, 1952. 686. Tassman, I. S.: Use of Hyaluronidase in Ophthalmology , Am. J. Ophth. 35:683-686, 1952. 687. Carriker, F. R.: Use of Hyaluronidase in Ophthalmology , Am. J. Ophth. 35:1765-1768, 1952. 688. Astley, R.: Use of Hyaluronidase in Paediatric Urography , J. Fac. Radiologists 3:286, 1952. 689. Thale, H. B.: Use of Lyophilized Hyaluronidase in Cosmetic Surgery About Face , Plast. & Reconstruct. Surg. 10:260-263, 1952. 690. Webb, W. R.: Effect of Hyaluronidase on Rate of Absorption of Subcutaneous Fluids , A. M. A. Arch. Surg. 65:770-773, 1952. 691. Butt, A. J.; Hauser, E. A., and Seifter, J.: Effect of Hyaluronidase on Urine and Its Possible Significance in Renal Lithiasis , J. A. M. A. 150:1096-1098, 1952. 692. Butt, A. J.; Seifter, J., and Hauser, E. A.: Effect of Hyaluronidase on Protective Urinary Colloids and Its Significance in Treatment of Renal Lithiasis , New Orleans M. & S. J. 104:754-758, 1952. 693. Faber, V.: Streptococcal Hyaluronidase: Review and the Turbidimetric Method for Its Determination , Acta path. et microbiol. scandinav. 31:345-354, 1952. 694. Di Caprio, J. M.; Rantz, L. A., and Randall, E.: Studies on the Streptococcal Hyaluronidase and Antihyaluronidase , A. M. A. Arch. Int. Med. 89:374-386, 1952. 695. Wattenberg, O. W., and Glick, D.: Mucolytic Enzyme Systems: XVIII. Purification of the Non-Specific Hyaluronidase Inhibitor in Human Blood , Arch. Biochem. 35:290-304, 1952. 696. Cole, J. W.; Cebul, F. A., and Holden, W. D.: Relationship of Liver to the Serum Nonspecific Hyaluronidase Inhibitor , Surgery 32:828-834, 1952. 697. Rantz, L. A.; Di Caprio, J. M., and Randall, E.: Antistreptolysin O and Antihyaluronidase Titers in Health and in Various Diseases , Am. J. M. Sc. 224:194-201, 1952 698. Forrest, J.; Overell, B. G.; Petrow, V., and Stephenson, O.: Some Observations on the Inhibition of the Action of Hyaluronidase on Hyaluronic Acid by Gentisic Acid and Its Oxidation Products , J. Pharm. & Pharmacol. 4:231-242, 1952. 699. Hahn, L.: Inhibitors of Hyaluronidase , Nature London 170:282-283, 1952. 700. Wasserman, A. E.: Streptokinase Activation of a Proteolytic Enzyme in Human Blood , Arch. Biochem. 41:158-165, 1952. 701. Johnson, A. J., and Tillett, W. S.: Lysis in Rabbits of Intravascular Blood Clots by the Streptococcal Fibronolytic System (Streptokinase) , J. Exper. Med. 95:449-463, 1952. 702. Friedman, M. W.: Streptokinase in Ophthalmology , Am. J. Ophth. 35:1184, 1952. 703. Knight, V.; Hardy, R. C., and Negrin, J. Jr.: Pseudomonas Aeruginosa Meningitis Treated with Streptokinase, Streptodornase, and Neomycin , J. A. M. A. 49:1395-1397, 1952.Crossref 704. Miller, J. M.; Long, P. H., and Stafford, E. S.: Clinical Experience with Streptokinase and Streptodornase in Tuberculosis , J. A. M. A. 148:1485-1489, 1952.Crossref 705. Miller, J. M., and Long, P. H.: Treatment of Hemothorax, with Particular Reference to the Use of Streptokinase and Streptodornase , U. S. Armed Forces M. J. 3:1061-1070, 1952. 706. Price, W. E., and Drinker, H. R., Jr.: Effect of Streptokinase-Streptodornase on the Urinary Bladder of the Dog and the Use of Streptokinase-Streptodornase for Dissolution of Clotted Blood in the Urinary Bladder of the Dog , Quart. Bull. Northwestern Univ. M. School 26:377-380, 1952. 707. Trice, P. A., and Townsend, T. E.: Meningitis Due to Klebsiella Pneumoniae: Use of Streptokinase and Streptodornase , J. A. M. A. 149:1471-1473, 1952.Crossref 708. Baum, G. L., and Oransky, P.: Unusual Reaction to Intrapleural Administration of Streptokinase and Streptodornase , J. A. M. A. 149:1012-1013, 1952.Crossref 709. Astrup, T., and Sterndorff, I.: Fibrinolytic Activity of Tissue Extracts and of Trypsin , Nature, London 170:981-983, 1952.Crossref 710. Müllertz, S.: Fibrinolytic and Fibrinogenolytic Methods for Estimating Plasmin and Trypsin , Acta physiol. scandinav. 26:174-182, 1952.Crossref 711. Innerfield, I.; Angrist, A., and Benjamin. J. W.: Studies on Trypsin: I. The Anticoagulant Action of Trypsin , Gastroenterology 20:630-635, 1952. 712. Steigman, A. J., and Scott, C. H.: Trypsin in Poliomyelitis Patients with Tracheomotomy , J. A. M. A. 150:1403-1404, 1952.Crossref 713. Farber, E. M.; Loeb, H. G.; McCleary, J., and Lincoln, C. A.: Treatment of Selected Dermatoses with Crystalline Trypsin Ointment , Stanford M. Bull. 10:186-187, 1952. 714. Loeb, H. G., and Farber, E. M.: Preparation and Duration of Activity of Trypsin Compound in an Ointment Base , Stanford M. Bull. 10:289-293, 1952. 715. Cooper, M. N.; Mitchell, G. L., Jr.; Bennett, I. L., and Cary, F. H.: Methyl Alcohol Poisoning: An Account of the 1951 Atlanta Epidemic , J. M. A. Georgia 16:48-49, 1952. 716. Pearson, A. T.: Acute Methyl Alcohol Poisoning , M. J. Australia 2:437-438, 1952. 717. Bralliar, F. B.: Methyl Alcohol Poisoning , U. S. Armed Forces M. J. 3:1029-1035, 1952. 718. Benton, C. D., and Calhoun, F. P.: Ocular Effects of Methyl Alcohol Poisoning: Report of a Catastrophe Involving 320 Persons , Tr. Am. Acad. Ophth. 56:875-885, 1952. 719. Potts, A. M., and Johnson, L. V.: Studies on the Visual Toxicity of Methanol: Effect of Methanol and Its Degradation Products on Retinal Metabolism , Am. J. Ophth. 35:107-113, 1952.
TI - PHARMACOLOGY AND TOXICOLOGY
JF - A.M.A. Archives of Ophthalmology
DO - 10.1001/archopht.1953.00920030197010
DA - 1953-08-01
UR - https://www.deepdyve.com/lp/american-medical-association/pharmacology-and-toxicology-9XIFlFosic
SP - 192
EP - 247
VL - 50
IS - 2
DP - DeepDyve
ER -